Stress oxydatif, fonction mitochondriale et maladie inflammatoire de l'intestin by Taha, Rame
 i
Université de Montréal 
 
 
Stress oxydatif, fonction mitochondriale et maladie inflammatoire de l’intestin 
 
 
 
 
par 
Rame Taha 
 
 
Département de Nutrition  
Faculté of Médecine 
 
 
 
Thèse présentée à la Faculté de Médecine 
en vue de l’obtention du grade de PhD 
en Nutrition 
 
 
 
 
Aout, 2011 
 
 
 
© Rame Taha, 2011 
 ii
Université de Montréal 
Faculté des études supérieures et postdoctorales 
 
 
 
 
Cette thèse est intitulée : 
 
Stress oxydatif, fonction mitochondriale et maladie inflammatoire de l’intestin 
 
 
 
 
 
Présentée par : 
Rame Taha 
 
 
 
 
a été évaluée par un jury composé des personnes suivantes : 
 
 
Dr Dominique Garrel, président-rapporteur 
Dr Emile Levy, directeur de recherche 
Victor Gavino, membre du jury 
Charles Ramassany, examinateur externe 
Christiane Malo, représentante du doyen de la FES 
 1
Résumé 
CONTEXTE: Bien que la dysfunction mitochondriale et le stress oxydant jouent des rôles 
prépondérants dans plusieurs conditions pathologiques, ils n’ont pas été étudiés de façon 
extensive au niveau du tube digestif qui est constamment exposé aux oxydants (provenant 
de l’alimentation) et à divers agents pathogènes. L’ingestion simultanée de sels ferreux et 
d’acide ascorbique peut causer le dommage des macromolécules par oxydation. Le 
‘’Nuclear factor erythroid 2 related factor’’ (Nrf2) est un important facteur de transcription 
sensible au potentiel redox et qui protège contre le stress oxydant en induisant des gènes 
anti-oxydants et de detoxification par sa liaison à l’élément de réponse antioxydante (ARE). 
Les fonctions anti-oxydantes et anti-inflammatoires de Nrf2 ont été décrites dans une 
variété de types cellulaires et de tissus. Cependant son rôle est très peu connu au niveau du 
tube digestif. OBJECTIFS: Les objectifs sont d’évaluer comment la peroxydation 
lipidique médiée par le fer/ascorbate (FE/ASC) affecte les fonctions  mitochondriales dans 
les cellules Caco-2/15, et de déterminer l’ampleur de l’implication de Nrf2. 
MÉTHODES: Le stress oxydant a été induit dans les cellules Caco2/15 en les traitant 
avec 0.2mm/2mm de FE/ASC. L’augmentation de l’expression de Nrf2 a été obtenue suite 
au prétraitement des cellules Caco2/15 avec 50 µM d’Olitpraz (OPZ), un puissant 
activateur. L’invalidation du gène de Nrf2 a été réalisée dans les cellules par transfection 
avec un vecteur lentiviral contenant un shRNA contre Nrf2. RÉSULTATS: Nos 
résultats montrent que le traitement des cellules Caco-2/15 avec du FE/ASC (0.2 mm/2 
mm) augmente les niveaux du malondialdehyde (MDA), réduit la production d’ATP, 
entraîne une surcharge mitochondriale de calcium, active l’expression protéique du 
cytochrome C et de l’AIF (apoptotic inducing factor), réduit l’activité des complexes I, II, 
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III et IV de la chaîne respiratoire  mitochondriale, augmente les niveaux de 8-OHdG, un 
marqueur des dommages à l’ADN mitochondrial, diminue la DNA glycosylase, et altère les 
expressions génique et protéique des facteurs de transcription mitochondriaux (mtTFA, 
mtTFB1, mtTFB2).  
De plus, nos observations montrent que l’induction et l’activation de Nrf2 dans les cellules 
Caco-2/15 résultent en: une  augmentation des enzymes anti-oxydantes endogènes 
(catalase, glutathion peroxydase, et superoxyde dismutase), une réduction du facteur 
nucléaire NFκβ  et de TNF-α,  une augmentation de la production d’ ATP et de l’activité 
des complexes respiratoires (I, II, III, IV) et de PGC-1α,  et une régulation des niveaux de 
la prohibitine mitochondriale, du Bcl-2 anti-apoptotique et de l’occludine. 
CONCLUSION: Dans l’ensemble, nos résultats montrent que l’exposition aigüe des 
cellules Caco-2/15 à la peroxydation par le FE/ASC entraîne des effets pathologiques sur 
les fonctions mitochondriales et l’intégrité de l’ADN, qui sont abolis par l’induction de 
Nrf2. Il en ressort que Nrf2 joue un rôle majeur dans la protection de l’épithélium intestinal 
contre le stress oxydant. 
  
Mots-clés : Stress oxydatif, Mitochondrie, Inflammation, Nrf2  
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Abstract 
Background: 
 Although mitochondrial dysfunction and oxidative stress are key mechanisms in various 
pathological conditions, they have not been extensively studied in the gastrointestinal tract, 
which is known to be constantly exposed to luminal oxidants from ingested foods and 
pathogens. Key among these is the simultaneous ingestion of iron salts and ascorbic acid, 
which can cause oxidative damage to macromolecules. The protein ‘’Nuclear factor-
erythroid 2- related factor’’ (Nrf2) is an important redox-sensitive transcription factor, 
which protects against oxidative stress by inducing antioxidant and detoxifying genes 
through binding with antioxidant response element (ARE). Many of Nrf2 antioxidant 
protective and anti-inflammatory functions have been established in various cells and 
tissues. However, limited information is available on its role in the gastrointestinal tract.  
 
Objectives:  
The objectives are to evaluate how iron-ascorbate (FE/ASC)-mediated lipid peroxidation 
affects mitochondrion functioning in Caco-2/15 cells, and to mechanistically determine the 
role of Nrf2.  
Methods: 
 Caco2/15 cells were treated with 0.2mm/2mm of FE/ASC to induce oxidative stress. To 
increase Nrf2 expression, cultured Caco2/15 cells were pre-treated with 50 µM Olitpraz 
(OPZ). To down regulate the Nrf2 function, Nrf2 gene was knocked down by transfecting 
Caco-2/15 cells with a pGFP-RS lentiviral vector containing shRNA against Nrf2.  
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RESULTS: 
Our results show that the treatment of Caco-2/15 cells with FE/ASC (0.2 mm/2 mm): 
increased the levels of malondialdehyde (MDA), a marker of oxidative stress; reduced ATP 
production; raised mitochondrial calcium content; regulated the protein expression of 
cytochrome C and apoptotic inducing factor (AIF); decreased mitochondrial respiratory 
chain complexes I, II, III and IV activity; prevented mtDNA damage as illustrated by the 
raised levels of 8-OHdG; lowered DNA Glycosylase, and altered the gene expression and 
protein mass of mitochondrial transcription factors (mtTFA, mtTFB1, mtTFB2).  
Furthermore, our observations indicate that the induction and activation of Nrf2 in 
Caco2/15 cells resulted in an augmentated endogenous antioxidants enzymes (catalase, 
glutathione peroxidase, and superoxide dismutase), a reduction of nuclear factor-kappaB 
(NFκβ) and Tumor Necrosis Factor- Alpha (TNF-α),  an increase in the ATP production, 
mitochondrial respiratory complexes (I, II, III, VI), PGC1α ,  and a regulation of the  
mitochondrial Prohibitin, anti-apoptotic Bcl-2 protein, and Occludin level.  
 
CONCLUSION:  
Findings indicate that acute exposure of Caco-2/15 cells to FE/ASC-catalyzed peroxidation 
produces pathological effects on mitochondrial functions and DNA integrity, which were 
diminished by Nrf2 induction. It appears that Nrf2 plays a critical cytoprotective role in 
intestinal epithelial cells against oxidative stress.  
 
Keywords : Oxidative Stress, Mitochondria, Inflammation, Nrf2  
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1 INTRODUCTION 
1.1 Oxidative Stress 
 
Oxidative stress can be defined as an imbalance between Reactive Oxygen Species (ROS) 
production and anti-oxidant defense as seen in (Fig.1).  
Oxidative stress
Low levels of  ROS
Proliferative signal
Intermediate 
levels of ROS
Apoptosis
High levels of ROS
Necrosis Beneficial
Harmful 
It is an imbalance between formation and neutralization of ROS
ROS
Superoxide
Hydrogen peroxide
Hydroxyl radical
Peroxynitrite
Anti-Oxidant
superoxide dismutase  
glutathione peroxidase
Catalase
Vit E,C
 
Figure 1: Oxidative stress 
 
The presence of potent cellular detoxification systems minimizes radical generation, 
terminates radical processes, and repairs damaged macromolecules. However, continued 
overproduction of ROS and free radicals can overwhelm antioxidant defense and become 
deleterious to cellular biological processes and tissue functions [1]. Oxidative stress has 
been implicated in a number of diseases that include atherosclerosis, cancer, and 
 14
neurodegenerative diseases, Parkinson’s disease, multiple sclerosis, aging and gastro-
intestinal. [1-4].  
 
1.1.1 Reactive oxygen species generation and oxidative damage 
 
ROS are free radicals with one unpaired electron derived from molecular oxygen. The most 
important free radicals are oxygen derivatives, particularly superoxide anion (O2–•), 
hydroxyl radical (OH-) and hydrogen peroxide (H2O2), as well as reactive nitrogen species 
such as nitric oxide and peroxynitrite.  Radical formation in the body occurs through 
several mechanisms, involving both endogenous and exogenous sources, such as 
environmental factors that lead to tissue damage as illustrated in (Fig. 2) [3, 4]. 
 
 
Figure 2: Major sources of free radicals in the body and the consequences of the free 
radical damage. Young IS J Clin Pathol. 2001 
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Under normal physiological conditions, ROS are generated by immune cells as a non-
specific defense mechanism against invading organisms, a low level of ROS constitutes 
inter- and intra-cellular signals, which are vital to maintain proper cellular function [3, 5]. 
In addition, immune cells, structural cells like epithelial cells, are also involved in the ROS 
production  
 
However, under pathological conditions, progressive and irreversible generation of ROS 
increases to a point where the antioxidant system cannot effectively counteract them, and 
results in impairing physiological functions [4-6]. Thus, depending on their cellular 
concentrations and duration, ROS can act as either beneficial or harmful agents, as shown 
in (Fig.3).   
Pathological
Physiological
Se
ve
re
M
ild
 
Figure 3: Mild (physiological) and severe (pathological) oxidative stress 
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High ROS concentrations (pathological condition) can affect various subcellular 
compartments that lead to oxidize mitochondrial enzyme complexes, plasma membrane, 
nucleic acids (nuclear and mitochondrial DNA), calcium homeostasis, lipid and protein 
damage as projected in Fig.4 [1, 3, 6].  
Maintaining the protein homeostasis via the regulation of protein unfolding and aggregation 
is crucial since it shares close relationship with other intracellular pathways, including 
oxidative stress and mitochondrial dysfunction to impact cell survival and death pathway. 
Under pathological conditions, the level of abnormal proteins may exceed the ability of the 
cell to degrade them, allowing aggregation to proceed.  Increased oxidative stress results in 
the accumulation of aggregated proteins that have been suggested to underlie the loss of 
cellular function.  
Oxidative damage modifies a large variety of proteins, including mitochondrial protein and 
proteins involved in signal transduction, which is often irreversible due to impairment in 
protein turnover and the need to be degraded by the ubiquitin protein system. However, 
these damaged proteins are prone to aggregate, poorly degraded and become toxic to the 
cell [7, 8].    
Oxidative damage to mitochondrial and nuclear nucleic acids causes modification of 
pyrimidine and purine bases and commonly mitochondrial and nuclear DNA damage, 
measured as increased in 8-hydroxydesoxyguanosine (8-OxO) [9]. Mitochondrial DNA is 
highly susceptible to ROS induced damage because it is located in close proximity to the 
production site of ROS, and the mt DNA repair mechanisms are limited. ROS induced mt 
DNA deletion leads to a decline in the mitochondrial function and enhances ROS 
production [9, 10].  
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Figure 4: Oxidative stress affects various compartments with macromolecules damage 
 
                
Furthermore, oxidative attacks to polyunsaturated fatty acids (PUFA) in mitochondrial and 
cellular membranes may trigger lipid peroxidation, resulting in oxidative breakdown of 
cellular membranes [6, 11].  
Mitochondria are a major source of ROS generation. In the mitochondria, O2–• can be 
produced by respiratory complexes, enzymes on the outer mitochondrial membrane, inner 
mitochondrial membrane and in the matrix [7]. Non enzymatic production of O2–•  occurs 
mainly in the mitochondria, particularly at complex I and III of the mitochondrial electron 
transport chain (ETC) [12].  
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Outside of mitochondria, several enzymatic systems are the major sources of O2–• that are 
responsible for the production of the intracellular ROS, including NADPH oxidases [13], 
xanthine oxidase [14] and cytochrome P450-dependent oxygenases [15].  
 
Any condition that results in over-consumption of oxygen can lead to the production of free 
radicals. It is estimated that up to 1-5% of the oxygen that is passed through the ETC inside 
the mitochondria results in O2–• production [16, 17]. 
 
O2 + e- → O2- Superoxide radical 
O2- + H2O → HO2 + OH- Hydroperoxyl radical 
HO2 + e- + H → H2O2 Hydrogen Peroxide 
H2O2 + e- → OH + OH- Hydroxyl Radical 
Under pathological conditions, O2–• can react with either luminal or mucosal iron through 
the Fenton reaction, to produce toxic and highly reactive OH•, leading to a more free 
radicals production. OH• is also formed from H2O2 through the Fenton reaction [18] or 
from O2–• through another transition metal-dependent reaction, called the iron-catalyzed 
Haber–Weiss reaction [19] and is considered to be the most reactive ROS [20]. 
 
H2O2 is generally considered as a relatively weak ROS that might directly damage proteins 
and enzymes containing reactive thiol groups. It has the ability to react with partially 
reduced metal ions, such as Fe2+ or Cu+, to form OH• in Fenton reaction [18]. 
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1.1.2  Iron over-consumption induce oxidative stress 
 
Free iron is a potential source of oxidative stress because it catalyses the conversion of 
H2O2 into highly OH•. Iron, like oxygen, is essential for life, but together they can form a 
highly ROS [21, 22]. The mucosal iron concentration has been observed to be significantly 
increased in the presence of inflammation, at least in part due to overproduction of free 
radicals via increased levels of free haemoglobin from mucosal ulceration and bleeding 
[23]. Subsequent increased in iron may trigger a self perpetuating cycle, resulting in further 
tissue damage and more inflammation [24]. 
 
High concentrations of iron decrease oxidative phosphorylation (OXPHOS) and the total 
electron transport proteins in the mitochondria. This disturbance of electron movement can 
lead to increased mitochondrial H2O2 production [25]. The combination of increased iron 
and the physiological concentrations of H2O2, generated in the mitochondria during 
OXPHOS might result in DNA damage [22, 26]. Thus, accumulation of mtDNA damage 
and subsequent decline in mitochondria function could be a primary cause in various 
chronic inflammatory diseases.  
Free radicals interact with iron and can potentially enhance intestinal inflammation through 
propagation of lipid peroxidation whereas ascorbic acid can amplify the oxidative potential 
of iron by promoting metal ion-induced lipid peroxidation [21, 23, 25]. Ascorbic acid, an 
essential micro-nutrient for the physiological metabolic function, has a significant 
antioxidant role by scavenging active oxygen species. On the other hand, the interaction of 
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ascorbic acid with free, catalytic active metal ions could participate in oxidative damage by 
releasing hydroxyl and alkoxyl radicals. This is further highlighted in patients receiving 
ferrous as a supplement, as ascorbic ferrous negatively affects the function of intestinal 
cells.  
Iron salts and ascorbic acid, frequently consumed together in multiple-vitamin preparations 
or ingested foods, form reactive hydroxyl radicals. Clinical observations suggest that oral 
iron supplementation is not well tolerated and may increase gastrointestinal symptoms and 
exacerbate disease activity [21, 23, 27]. Thus the cross-talk between iron homeostasis and 
intestinal inflammation will yield new insights into the pathogenesis of chronic 
inflammatory diseases and may suggest new therapeutic approaches for these diseases. 
 
Under normal condition, transition metal ions, such as iron and copper, are kept sequestered 
in cytosol by a number of chelating proteins like ceruloplasmin, ferritin and transferrin 
given their capacity to aggravate ROS generation. This large amount of chelating iron is 
released in response to oxidative stress [22]. At the same time, mitochondria are taken up 
the released chelating iron from cytosol, which may play a critical role in augmenting 
oxidative stress.  
 
1.1.3 Antioxidant: definition and classification 
 
Antioxidants have been defined as substances that are able, at relatively low concentrations, 
to significantly reverse the increase of ROS. Antioxidants cannot prevent ROS generation; 
they rather bring into balance the effects of ROS function.  
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The physiological role of antioxidants is to prevent cellular damage arising as a 
consequence of free radicals generation. In many disease states, however, mechanisms that 
prevent or limit ROS damage may become inadequate. In general, antioxidants prevent free 
radical-induced tissue damage by preventing the formation of radicals, scavenging them or 
promoting their decomposition [4, 28].  
The most primary antioxidants counteracting free radicals are either enzymatic such as 
intracellular Superoxide Dismutase (SOD), Catalase (CAT) , or non-enzymatic antioxidants 
that include vit C, E, and A [3, 7] as seen in Fig. 5   
 
 
Fig. 5: Antioxidant defenses against free radical attack, Young IS J Clin Pathol. 2001  
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There are three forms of SOD in the mammalian tissues, each with a specific subcellular 
location and different tissue distributions: 
 (1) Copper zinc superoxide dismutase, found in the cytoplasm.  
(2) Manganese superoxide dismutase, located in the mitochondria.  
(3) Extracellular superoxide dismutase, expressed on the cell surface [29, 30]. 
There are several dietary compounds with antioxidant properties, non-enzymatic 
antioxidants, normally originating from natural sources, such as fruits, vegetables and plant 
extracts that play a key role in the host defense and cell survival. In particular, certain 
minerals (e.g. Zinc), vitamins (C and E) and the flavonoids found in these extracts are 
considered to be of prime interest [4,31- 35]. Furthermore, the human gut naturally contains 
a variety of non-enzymatic antioxidant defences. These include water-soluble agents, such 
as glutathione and ascorbic acid (vitamin C), as well as lipid-soluble defences, such as α-
tocopherol (vitamin E) and ubiquinol (reduced co-enzyme Q10) [2, 4, 33-36]. 
 
Glutathione (GSH) is a significant intracellular peptide with multiple physiological 
functions, including antioxidant defensive actions as well as regulatory mechanisms that are 
able to promote intracellular  processes. Additionally, GSH important functions include: 
 (A) The reduction of various oxidative insults. 
 (B) The maintenance of the basic structure of protein thiols.  
(C)  Maintaining of the cysteine reserve. 
 (D) The modulation of DNA synthesis and immune function.  
(E)  An anti- apoptotic function [31, 32] 
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Although evidence shows that antioxidant treatment results in beneficial effects, the clinical 
benefit from antioxidants is still under wide debate. This remains an important area for 
future investigation, as researchers attempt to augment intracellular antioxidant, either by 
dietary supplementation of antioxidants or by overexpressing genes or transcription factors 
such as Nrf2 encoding antioxidant enzymes, which I will discuss in details in the 2nd part of 
my thesis. 
1.1.4  Oxidative stress and intestinal inflammation  
 
The intestine represents a key defense barrier against luminal toxic agents. Thus, in 
addition to being exposed to luminal nutrients, the intestinal mucosa is constantly 
challenged by diet-derived oxidants, mutagens, and carcinogens as well as by endogenously 
generated free reactive radical [23, 24]. 
The primary event of the induction of cellular oxidative stress is the inflammatory cascade 
of neutrophil adherence to vascular endothelial cells, disruption of the endothelial barrier, 
and subsequent infiltration of inflammatory cells into the intestinal wall, where oxidants 
and proteases are released to produce mucosal injury [37].   
Oxidative stress appears to be a primary causal factor in generating and maintaining a 
chronic intestinal inflammation, which is characterized by the activation of neutrophils and 
macrophages, as well as generation of numerous pro-inflammatory mediators, including IL-
1β , tumour necrosis factor alpha (TNF-α) ,  IL-8 and IL-6 [38-40].  It is well known that 
TNF-α is involved in ROS production; ROS in turn activate nuclear factor- kappa B (NF-
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κβ), which then enhances further TNF-α production, making a vicious cycle of excessive 
oxidative stress production [41-43] as appears in (Fig.6 ).  
Oxidative stress Inflammation
Inflammation-Oxidative stress vicious cycle
Pro inflammatory cytokines
• TNF-α
• IL-6
• IL-1β
• IL-8
Reactive oxygen species 
•Superoxide
• Hydrogen peroxide
• Hydroxyl radical
• Peroxynitrite
 
Figure 6: Inflammation and oxidative stress vicious cycle 
 
There is an evidence that ROS and pro-inflammatory cytokines work synergistically as 
activators of NF-κβ and activator protein-1, thereby modulating their activity [44]. 
However, activation of NF-κβ has been specifically implicated in maintaining inflammation 
by the activation of a variety of inflammatory genes [45].  
 
Enhanced NF-κβ signalling in the gut epithelium initiates the primary events of intestinal 
inflammation and leads to defects in the intestinal epithelial barrier. A recent study by 
Banan et al suggests that the loss of intestinal epithelial barrier function caused by the 
exposure to oxidants is lessened by inhibition of NF-κβ activity [27, 40]. There is an 
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increasing awareness of a role for cellular thiol redox status in NF-κβ activation and gene 
expression. Staal et al showed that low thiol concentrations promote NF-κβ activation, 
suggesting that intracellular thiol status has a key role in regulating gene activation [46].  
 
Studies on TNF-α -mediated inflammation have linked TNF-α induced mitochondrial 
oxidant production with induced NF-κβ activation [29].  Interestingly, Cogswell et al have 
found that NF-κβ and IκΒ-α  are localized in the mitochondria and can negatively regulate 
mitochondrial gene expression in response to cellular TNF-α stimulation. Furthermore, 
mitochondrial exposure to TNF-α  has confirmed the loss of expression of cytochrome C 
oxidase and cytochrome b mRNA, which down-regulates mitochondrial biogenesis [47]. 
 
TNF-α−induced oxidative stress and mitochondrial dysfunction in cell lines and tissues are 
evident in several patho-physiological conditions. In cardiac tissues, Maria pan N et al have 
shown that TNF-α induction leads to defects in mitochondrial permeability transition pore 
(PTP) proteins, resulting in pore opening, cytochrome C release and subsequently leading 
to apoptosis and mitochondrion dysfunction in cardiac tissues [48, 49]. 
 
The various mechanisms whereby activation of TNF- α modulates chronic inflammation 
and mitochondrial damage in gastro-intestinal diseases remain to be elucidated. Such 
ROS/cytokine-/transcription factor regulatory network loops may contribute to the 
perpetuation and exacerbation of chronic inflammation and tissue damage, particularly 
when the local immune response fails to successfully down-regulate the immune reaction.  
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Increased levels of TNF-α have been found in serum, mucosa and stool of patients with 
inflammatory bowel diseases (IBD) [50, 51]. Several clinical trials have shown that anti-
TNF-α antibody is effective in the treatment of intestinal inflammation, supporting the 
importance of TNF-α in the ongoing regulation of epithelial barrier functions in association 
with increased apoptosis [52, 53].  
 
1.1.5 Intestinal permeability and tight junction proteins 
 
The mucosal barrier is established by the single layer of intestinal epithelial cells. The 
intestinal epithelium is a polarized monolayer of columnar epithelial cells, which forms a 
barrier between the luminal contents and the mucosa. Its role is to achieve an efficient 
absorption of nutrients, water and ions, while preventing the uptake of noxious antigens, 
microbes and toxins. Epithelial permeability is influenced by the integrity of the epithelial 
cell layer and the basement membrane, as well as by the surface mucus layer and by 
autonomic nervous system functions [54, 55].    
 
In intestinal inflammation, lipid peroxidation causes disruption of mucosal barrier function, 
increased permeability and a reduction of tight junction proteins functions, which 
ultimately leads to alterations in cellular metabolism [56]. Epithelial barrier dysfunction 
and inflammation are major contributors to the pathogenesis of gastro-intestinal diseases. 
However, much remains unknown about how these two processes contribute independently 
to disease initiation. 
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The movement of particles in both small and large intestinal parts occurs through two 
pathways: paracellular and/or transcellular. Numerous stimuli, including microbial 
components, smoking, anti-inflammatory drug use and proinflammatory cytokines, can 
regulate paracellular permeability [54]. The integrity of epithelial barrier is dependent on 
the function of tight junctional proteins (TJs) located near the apical poles of two adjacent 
epithelial cells. TJs are composed of multiple proteins (claudin family, occludin, zonula 
occludin-1) that are involved in establishing the epithelial barrier, and they selectively 
determine which molecules are able to traverse the paracellular space [57-59].  
 
Occludin was the first identified transmembrane protein of this intercellular junction. TJs 
seem to interact together as networks and it appears that occludin interacts, directly or 
indirectly, with claudin. Conceivably, occludin has increased electrical resistance by 
influencing the extracellular conformation of Claudins [57, 58]. 
 
The TJs are dynamic structures that are rate limiting for passive absorption of hydrophilic 
molecules in the intestine, which should be determined by intestinal permeability [59]. 
Thus, TJs dysfunction may be an important source of the overall intestinal barrier defects, 
leading to increased permeability very often seen in patients with chronic intestinal 
inflammation. In vitro experiments examining the effects of inflammatory cytokines on 
model intestinal epithelial cells suggest that disruption of the epithelial barrier is associated 
with internalization of transmembrane TJ protein such as occludin [55, 60, 61]. 
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1.2 Mitochondria   
 
1.2.1 Mitochondrion structure and function  
 
Human mitochondrion contains multiple copies of a small double-stranded DNA genome 
that encodes 13 proteins (subunits of complexes I, III, and IV and the ATP synthase 
complex), 2 Ribosomal Ribonucleic Acids (RNAs), and 22 transfer RNAs that are needed 
for mitochondrial DNA translation.  Therefore, these organelles represent a critical 
intracellular target for oxidative damage, which may lead to lethal injury through the loss of 
electron transport, mitochondrial membrane potential and ATP generation [12, 62, 63]. 
 
The mitochondrial genome is transcribed by machinery that includes RNA polymerase, the 
mitochondrial transcription factor A (mt TFA) and two mitochondrial transcription factors, 
mt TFB1 or mt TFB2 [64]. Although mitochondria have their own genome, most of the 
proteins and enzymes that reside in mitochondrial membranes are nuclear gene products. 
Mitochondria possess both an outer and inner membrane, the latter of which has a larger 
surface area, is impermeable to all molecules and contains the enzymes responsible for 
OXPHOS and ATP production as seen in (Fig. 7) 
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Figure 7: Mitochondrial structure 
 
Mitochondria are multifunctional organelles that receive, integrate and transmit signals [65] 
and are involved in numerous metabolic activities, including ATP production, (OXPHOS), 
ROS generation and detoxification, calcium (Ca2+) homeostasis and regulation of apoptosis 
pathways [65-67].   
1.2.2 Electron Transport Chain Complexes and ATP production 
 
Mitochondria produce 90% of the required energy necessary for cellular function via 
adenosine-5'-triphosphate (ATP) production either by anaerobic glycolysis or by 
mitochondrial OXPHOS. During OXPHOS, electrons from reduced substrates are 
transferred to O2 through (ETC), including complex I, III, and IV, which in turn generate a 
proton gradient across the mitochondrial inner membrane [12, 66, 68]. The electrochemical 
energy of this gradient is then used by complex V, which couples H+ reuptake with ADP 
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phosphorylation in the matrix to generate ATP [69]. It appears that any blockage in the 
ATP production result in a severe impairment of one or more of these complexes. Excess 
electrons, however, may react with oxygen to form more ROS production that plays a key 
role in creating oxidative stress [70] as shown in (Fig.8).  
 
Figure 8: Summary of protein subunits of the five Respiratory chain complexes 
encoded by nuclear and mitochondrial genes 
 
1.2.3 Mitochondrial function and oxidative stress 
 
Mitochondria produce the energy needed for normal cellular function and metabolic 
homeostasis by OXPHOS and serve as biosensors for oxidative stress. Mitochondria 
constitute a major source of free radicals in cells, resulting in oxidative stress, but are also 
targets to oxidative stress action. Although the molecular mechanisms responsible for 
mitochondrion-mediated diseases are not fully elucidated, yet oxidative stress appears to be 
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a pivotal player. Hence, it is apparent that mitochondrial damage may lead to the 
impairment of various aspects of tissue functioning.  
 
It is now appreciated that the reduction of mitochondrial oxidative stress may prevent or 
slow down the progression of many mitochondria dysfunctions related to oxidative stress 
diseases, including aging, obesity, diabetes and neurodegenerative disorders [10, 70-73]. 
However, if mitochondria are the major source of intracellular ROS and mitochondria are 
most vulnerable to oxidative damage, then it would be ideal to deliver the antioxidant 
therapy to mitochondria [74]. 
 
Dietary antioxidants are widely used to ameliorate excessive oxidative stress, but scientific 
proof of their efficacy is poor. The currently existing antioxidants are not very effective in 
overcoming oxidative stress-mediated diseases. One of the reasonable answers for the 
failure of antioxidants to show clear therapeutic effects is their incapacity to reach 
mitochondria. There are currently growing efforts in developing mechanisms for the 
targeted delivery of antioxidants to mitochondria [74, 75]. More recently, confocal imaging 
studies in Caco-2 cells show that intracellular distribution of SS-19 tetrapeptidase 
antioxidant resembles that of MitoTracker, which localizes in mitochondria [76].  
 
1.2.4 Mitochondrial DNA damage related to oxidative stress 
 
Increased Oxidative Stress may contribute to alterations in the abundance of mitochondria 
as well as the copy number and integrity of mt DNA in human cells, which is vulnerable to 
oxidative damage because it is situated much closer to the site of ROS generation, in 
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particular since mitochondria lack protective histones and have much more reduced base 
excision repair mechanisms [73].   
Oxidative stress has been one of the risk factors that induce gut malignancy. If oxidative 
stress is irreversible, these damages lead to mutagenesis and carcinogenesis [77]. The 
accumulation of mt DNA mutations cause the loss of mitochondrion ability to produce 
sufficient energy to meet cellular needs and serves as a trigger for mitochondrial 
dysfunction and apoptosis [78]. Mutated mtDNA shows ~10- fold more mutation rates than 
nuclear DNA in relationship with increased free radical production, thereby leading to a 
vicious cycle that progressively stimulates the rise of oxidative stress and leads to impaired 
mitochondrial function.  
Oxidative DNA damage was measured by the production of 8-hydroxy-deoxy-guanosine 
(8-OHdG). This molecule (8-OHdG), which is more specific for mt DNA, is of practical 
importance because it is easily measurable and has therefore been proposed as a useful 
marker of oxidative stress [9, 79].  Human cells have developed different repairing 
enzymes, the most important being 8-oxo DNA Glycosylase (OGG1) that protects against 
the effects of oxidized DNA bases and preferentially removes 8-OHdG opposite cytosine 
[79, 80]. In mitochondria, OGG1 is thought to prevent activation of the intrinsic apoptotic 
pathway in response to oxidative stress by augmenting DNA repairing mechanisms [73].  
It has been proposed that mt DNA damage can lead to inhibition of ETC, increased ROS 
production, loss of mitochondrial membrane potential, and released signals for cell death, 
such as cytochrome C and AIF [62, 81, 82]. Therefore, mt DNA damage represents an 
important target for intervention and a biomarker in the course of many human diseases. 
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1.2.5 Oxidative stress induce mitochondrial calcium overload 
 
Mitochondria may have an impact on Ca2+ signals and functions as a buffer to stabilize 
calcium concentrations within the cell [83, 84]. Thus, mitochondrial Ca2+ is considered as a 
physiological regulator to balance mitochondrial ATP output and cellular ATP demand.  
 
A growing body of evidence suggests that Ca2+  channels, which control Ca2+ efflux from 
the endoplasmic reticulum (ER) in response to different biochemical signals, are sensitive 
to small changes in ROS concentrations, suggesting that these Ca2+ channels serve as 
physiological redox sensors [67, 84]. Under physiological conditions, Ca2+ released from 
the ER during cell activation is taken up by mitochondria to promote OXPHOS.  
 
During oxidative stress, there is a rapid increase in cytosolic Ca2+, which is followed by 
mitochondrial Ca2+ over loading [85]. At its turn, Ca2+ overload can lead to induced ROS 
production and another potential vicious cycle develops, thereby triggering mitochondrial 
(PTP) opening and cytochrome C release and resulting in apoptosis. 
 
The exact mechanism of mitochondrial Ca2+ induced ROS generation is unclear, although it 
may involve changes in the three-dimensional conformation of the respiratory complexes 
[72]. Specifically complex results in an increase of H2O2 production and inhibits OXPHOS, 
which may provoke an irreversible reduction in the energy status, thereby initiating patho-
physiological processes in certain cells [86, 87]. 
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A recent study suggests that disruptions in intracellular Ca2+ mobilization may contribute to 
the dysmotility of colonic smooth muscles in murine dextran sulfate sodium (DSS)-colitis 
by enhancing NF-κβ activity [88]. Furthermore, Di Sabatino A et al have provided 
evidence that the suppression of Ca2+ overloading may inhibit pro-inflammatory cytokine 
release in inflamed gut. Therefore, Ca2+ channel inhibitors might reduce mitochondrial Ca2+ 
overload, decrease mitochondrial ROS accumulation, improve mitochondrial energy 
production  and have the potential to ameliorate mitochondrial oxidative stress-mediated 
diseases [89]. 
 
1.2.6 Mitochondrial dysfunction and apoptosis  
 
Apoptosis, known as programmed cell death, plays a vital role in all stages of cell 
development. Mitochondria play a checkpoint of apoptotic signalling and integrate various 
types of proapoptotic endogenous signals incoming from other organelles, including 
nucleus, cytosol and lysosomes as well as exogenous factors including specific viral 
proteins or xenobiotics [62, 81].  
 
Apoptosis may be triggered by extracellular signals (extrinsic pathway) or by intracellular 
processes (intrinsic pathway). An increased mitochondrial formation of ROS triggers the 
intrinsic pathway by increasing permeability of the outer mitochondrial membrane through 
the opening of PTP, leading to collapse of mitochondrial membrane potential, along with 
release of apoptogenic mitochondrial proteins into the cytoplasm, which triggers a cascade 
of events, leading to apoptosis [62, 90] as seen in (Fig. 8).  
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The release of different proteins from the mitochondria is a critical early event in 
mitochondrial mediated apoptotic cell death. Cytochrome C is such a protein that, upon 
releasing into the cytosol, forms a complex with procaspase-9, resulting in the activation of 
the caspase cascade and ultimately in apoptosis [26, 62, 82]. Early release of cytochrome C 
would be the early sign of apoptosis and suggests the occurrence of mitochondrial 
dysfunctions along with apoptosis development [76]. The gradual loss of cytochrome C 
from the intermembrane space during apoptosis favours the mitochondrial formation of O2–
• in two ways: (1) cytochrome C is a scavenger of O2–• and (2) as cytochrome C is released, 
the electron flows between Complex III and Complex IV, slows down, and the respiratory 
chain becomes more reduced [82, 91].  
 
The mechanism of cytochrome C release connects the upstream event of cytochrome C 
(i.e., dissociation from cardiolipin). Hence, cytochrome C must first dissociate from the 
inner membrane in order to escape mitochondria. Therefore, oxidation of cardiolipin may 
be one mechanism by which cytochrome C is solubilized in the intermembrane space [26, 
76].  
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Figure 9: Caspase-depended (Extrinsic) pathway and caspase- independed (intrinsic) 
pathway 
 
Apoptosis is also initiated by mitochondrial intermembrane space protein called AIF, 
involved in initiating a caspase-independent pathway of apoptosis (positive intrinsic 
regulator of apoptosis) through DNA fragmentation and chromatin condensation [62]. AIF 
normally stabilizes mitochondrial membrane permeability and supports OXPHOS. 
However, if released through the outer membrane into the cytosol, AIF can produce 
terminal damage to n DNA [92]. 
Apoptotic pathways contain counter balancing concentrations of anti-apoptotic and pro-
apoptotic Bcl-2 family [93]. These proteins are normally found in the cytosol but can be 
induced to target mitochondria. All of these Bcl-2 family proteins are encoded within the 
nuclear genome, transported into mitochondria and stored in the space between the inner 
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and outer membranes [94]. Under physiological conditions, anti-apoptotic Bcl-2 remains 
bound to the outer membrane and prevent the mitochondrial PTP. In contrast, when pro-
apoptotic factor like Bax is induced and translocated to mitochondria, it initiates the 
apoptosis process [91]. The relative ratio of anti- and pro-apoptotic Bcl-2 family proteins 
dictate the ultimate sensitivity of cells to various apoptotic stimuli, including oxidants and 
Ca2+ overload [62, 91]. 
 
Bcl-2 family proteins regulate the release of cytochrome C, AIF and certain caspases 
(caspase-2, -3, and -9) from mitochondria. Pro-apoptotic Bcl-2 enhances release of this 
caspase-activating protein and anti-apoptotic members of the family, which stops 
cytochrome C release [62, 81]. Furthermore, it has been suggested that the anti-apoptotic 
functions of Bcl-2 may be (at least in part) associated with depletion of ER Ca2+, thus 
indirectly reducing mitochondrial Ca2+ uptake [67].   
 
1.2.7 Prohibitin protects mitochondrial dysfunction  
 
Prohibitins (PHB) are ubiquitous chaperone proteins forming a ring-like, high-molecular-
mass complexes that are mainly localized in the inner mitochondrial membrane, help in the 
stabilization of mitochondrial respiratory enzymes and mitochondrial membrane proteins, 
and are implicated in mitochondrial biogenesis, mitochondrial function, mitochondrial 
morphogenesis and apoptosis [95]. Deficiency of the PHB complex results in increased 
ROS production or sensitivity to free radicals [96]. Abnormal PHB levels have been 
reported in mitochondrial dysfunction related to oxidative stress diseases, including obese 
patients at risk for non-alcoholic steatohepatitis, parkinson disease, schizophrenia [97, 98]. 
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Interestingly, it has been also found that PHB expression is down-regulated in intestinal 
diseases in experimental colitis in vivo and during oxidative stress in vitro. Furthermore, 
Theiss et al  have shown that TNF-α decreases PHB expression in intestinal epithelial cells, 
and restoration of PHB expression in these cells can protect against the various effects of 
TNF-α and NF-κβ on intestinal barrier function [99, 100]. More recently, it has been 
shown that PHB is a regulator of Nrf2 expression in intestinal epithelial cells during 
oxidative conditions that prevent inflammation-associated oxidative stress and injury 
through sustained activation of Nrf2. The above findings emphasize the importance of the 
PHB complex in maintaining mitochondrial homeostasis that is crucial for human health. 
 
1.2.8 Nucleus-mitochondrial cross talk, role of PGC-1 α  
 
Mitochondrial functions must rely on an orchestrated cross-talk between nuclear and 
mitochondrial genes and it clearly appears that the nucleus has a dominant role in the 
regulation of mitochondrial activity. Nuclear transcriptional factors control the activity of 
mitochondrial genome and coordinate the expression of both nuclear and mitochondrial 
genes encoding mitochondrial proteins. Nonetheless, nuclear gene expression can be 
influenced by signals derived from mitochondria, through retrograde communication, so 
that the regulation of mitochondrial activity is exposed to a bidirectional flow of 
information [101, 102].   
Crosstalk between nucleus and mitochondrial genes contribute to mitochondrial protection 
against oxidative stress via enhancing antioxidant defense through the Nrf2 pathway that 
 39
acts on the genes coding for constituent subunits of the OXPHOS system and mtDNA 
replication or by stimulating mitochondrial biogenesis through the activation of peroxisome 
proliferation activator receptor γ-coactivator 1α pathway (PGC-1 α) [68, 103].  PGC-1α 
may serve as an adaptive set-point regulator, capable of providing an accurate balance 
between metabolic requirements and cytotoxic protection. Therefore, its dual activities of 
inducing mitochondrial biogenesis and suppressing ROS make PGC-1α an almost ideal 
target protein for the control damage associated with mitochondrial dysfunction. 
 
PGC-1α  interacts with Nrf-2 to transactivate a number of genes involved in mitochondrial 
functions such as OXPHOS regulation, protein import and heme biosynthesis. It also 
mediates mt DNA transcription and replication through two nuclear-encoded genes, the mt 
TFA and B (mt TFB) [103, 104]. It is suggested that the Nrf-2 pathway could be affected at 
the levels of transcription, translation or protein levels.  
 
Surprisingly, a more recent study has shown that mice with a targeted disruption of PGC-
1α are viable and show no changes in mitochondrial abundance or morphology in liver or 
brown fat [104]. The retrograde or compensatory pathway has been proposed: free radicals 
generated from respiratory chain are involved in the signalling pathway from mitochondria 
to the nucleus in order to enhance the expression of nuclear genes involved in 
mitochondrial biogenesis such as Nrf2 [101, 102].  
 
1.2.9 Mitochondrial dysfunction related to oxidative stress 
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Mitochondrial dysfunction has gained more attention in recent years, whereby electrons 
leaking from the ETC generate ROS that in turn damage ETC components and 
mitochondrial DNA, which leads to an additional increase in intracellular ROS levels and  
defects in mitochondrial functions [48, 105, 106]. Because dysfunctional mitochondria will 
produce more ROS, a feed-forward loop is set up whereby ROS-mediated oxidative 
damage to mitochondria favours more ROS generation, then resulting in a vicious cycle. 
This mitochondrial dysfunction causes cell damage and death by compromising ATP 
production, disruption of calcium homeostasis, damage of mt and nuclear DNA, increases 
in cytochrome C and AIF release, impairment in various proteins and lipid peroxidation 
(Fig 10): 
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Figure 10: Mitochondrial dysfunction events related to oxidative stress 
 
 41
Since mitochondria are attractive targets for drug-delivery strategies, it would be ideal to 
deliver the antioxidant therapy directly to mitochondria [75]. The mitochondrial outer 
membrane is permeable to small molecules, and thus the inner membrane represents the 
major barrier for drug delivery to mitochondria. However, mitochondria-targeted 
antioxidants research is still in infancy and needs sufficient time to yield more reliable data. 
1.2.10 Implication of oxidative stress and mitochondrial dysfunction in inflammatory 
bowel diseases 
 
Inflammatory Bowel Diseases (IBD) are idiopathic, chronic and relapsing inflammatory 
conditions of the gastrointestinal tract. They are recognized as important causes of gastro-
intestinal diseases in children and adults and are common in highly industrialized western 
countries [107, 108]. Crohns Disease (CD) and Ulcerative Colitis (UC) are the two main 
clinic-pathological subtypes of IBD [109, 110]. 
 
Although the incidence and prevalence of IBD are beginning to stabilize in high-incidence 
areas such as North America and Northern Europe, they continue to rise in low-incidence 
regions such as Southern Europe, Asia, and much of the developing world [111, 112]. 
There are about 201,000 Canadians living with IBD: 112,500 with CD and 88,500 with 
UC. Canada is among the highest reported prevalence and incidence of IBD in the world 
[113]. Economic costs in 2008 for IBD are estimated at $1.8 billion per year in Canada 
[114, 115]. There has been a significant increase in IBD morbidity that exerts enormous 
economic burden and makes IBD a public health issue [114, 116].  
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No precise aetiology has been identified for IBD. Epidemiological studies have stressed the 
involvement of environmental and genetic factors and especially anomalies in the immune 
system in response to microbial infections [108, 110] as seen in Fig.11.  
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Figure 11: IBD risk factors 
 
The strongest environmental factors being identified are smoking and diet [113, 117, 118]. 
It is clearly established that smoking is the most consistently environmental risk factor 
reported to be associated with CD. A meta-analysis suggests that smokers are more than 
twice likely to develop CD compared to non-smokers [119, 120]. Several other studies have 
considered the role of dietary factors in the pathogenesis of IBD, while immunological 
mechanisms have been suggested to link food antigens to the development of intestinal 
inflammation [121].  
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It is postulated that the higher incidence of IBD seen in developed countries may be 
associated with dietary habits. Persson et al suggest that frequent fast food intake and 
increased simple sugar consumption confer a 3-to-4-fold greater risk for IBD [122]. 
Whether other suggested factors such as western life-style, social and occupational status, 
psychological stress, sanitation, appendectomy, drugs and exposure to infections play a role 
in the expression of IBD remains unclear [123-126] .  
 
Previous findings suggest that IBD incidence appears linked to race. A strong genetic 
component in IBD aetiology is most likely related. Some epidemiological data support this 
hypothesis: (1) the heterogeneity in the geographical distribution of IBD, (2) the existence 
of familial forms of IBD and (3) the high rate of concordance in monozygotic twins [127-
130]. 
 
Various mechanisms have been discussed concerning immune dysfunction in IBD, 
including defects in immune response to normal luminal components, and/or defective 
mucosal barrier to luminal antigens such as diet and enteric bacteria [131, 132] as seen in 
Fig. 12. 
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Figure 12: Pathopghysiology of IBD 
 
The intestinal epithelium is the first host defense against invading pathogens and food 
antigens acting as key mediators of communication between the intestinal lumen and 
mucosal immune system. The gastrointestinal mucosa is constantly exposed to luminal 
oxidants from ingested foods that might contain iron salts and ascorbic acid [21, 131].  
 
The ingestion and/or occurrence of peroxides may have significant implications in human 
health in the long term. In this regards, ROS metabolites have been suspected to provoke  
injury to intestinal mucosa in various diseases, including intestinal ischemia and subsequent 
reperfusion, as well as IBD [133, 134]. 
 
Oxidative stress is currently considered among the most plausible explanations for IBD in 
human [3, 35, 134, 135]. Markers for oxidative damage can be measured in plasma, urine, 
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or post-mortem tissue by means of HPLC and immunohistochemistry [4, 33]. The 
increased in malonyldialdehyde (MDA), CH2 (CHO)2, levels found in plasma and colonic 
biopsies from CD patients provide evidence for excess lipid peroxidation reactions [134, 
136]. Furthermore, the increased breath ethane and pentane excretion in CD patients, which 
are non-invasive markers of lipid peroxidation, have been correlated with disease activity 
[35].  
The oxidative stress parameters in CD will be as follow: 
1. Breath ethane output (pmol•kg-1•min-1) 
2. Breath pentane output (pmol•kg-1•min-1) 
3. F2-isoprostane (ng/L) 
4. MDA 
There are many studies supporting the notion that a decline in antioxidant activity occurs 
with CD. Lih-Brody et al found a decrease in SOD in the mucosa of CD patients [137], 
which was correlated to the activity of the disease [30]. Furthermore, Buffinton GD et al 
observed a reduction of total glutathione in inflamed mucosa of patients with CD compared 
to normal tissue areas [138].  
 
Interestingly, reduced levels of PHB during intestinal inflammation may be one underlying 
factor that contributes to oxidant-induced mucosal barrier and intestinal permeability 
dysfunction [99, 100]. Finally, in a more recent report, Beltran B et al have demonstrated 
that ROS are directly implicated in the oxidative damage that occurs in CD patients. 
Additionally, mitochondrial membrane potential of CD cells is significantly inhibited 
compared to control cells and correlates significantly with markers of inflammation [139]. 
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Surprisingly, even if oxidative stress occurs in the intestinal mucosa, limited studies have 
explored the response of mitochondria to oxidative stress in the intestinal tissue in relation 
with the key cellular regulatory processes, including (ATP) production, intracellular 
calcium regulation, cell signaling, ROS generation and apoptosis.   
 
A number of findings have suggested that mitochondrial pathology related to OS may be 
associated with CD. Mitochondrion morphological changes have been observed in 
epithelial cells in tissues resected from patients with CD and in animal models of gut 
diseases [140, 141]. Farhadi et al discussed that mitochondrial damages were noted in 
intestinal epithelial cells and mucosal protein oxidation in stressed CD patients [100]. 
Furthermore, Soderholm et al. observed the presence of numerous swollen and irregular 
mitochondria in the epithelium of colonic segments from stressed rats [39]. O'Morain et al, 
on the other hand, showed mitochondrial damage through examining rectal biopsies 
obtained from CD patients [142].  
 
Furthermore, Plasma levels of 8-OHdG was found to be increased in CD patients compared 
to controls [143, 144]. It has also been shown that 8-OHdG levels were significantly higher 
in active CD, inactive CD and CD patients in remission compared to controls [139]. A 
recent report provides evidence on the association between intestinal inflammation, 
oxidative stress, DNA repair enzyme OGG1 and carcinogenesis. OGG1 (-/-) mice 
developed a significantly higher number of adenocarcinomas in the DSS colitis model 
compared to wild type mice [80]. Finally, a recent case report on a young girl with CD 
disclosed impaired OXPHOS along with abnormalities in Complexes III and IV [103]. 
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1.3 Nuclear transcription factor (Nrf2)  
 
1.3.1 Nrf2 structure and functions 
 
Nrf2, a basic leucine-zipper motif transcription factor, plays a key role in the regulation of 
phase II genes by binding to the ARE element in their promoters in conjuction with small 
Maf proteins [145, 146]. Nrf2 is one of the redox sensitive transcription factors, which gets 
activated in response to the increase in ROS. It attempts to restore the redox haemostasis by 
transcribing antioxidant proteins. Nrf2 is found in most tissues but is mostly abundant in 
the brain, liver, kidney and systems that are exposed to external environmental stresses like 
the gastrointestinal tract and skin [146]. Nrf2 has various cytoprotective functions and acts 
as antioxidant and anti-inflammatory factor capable to regulate mitochondrial biogenesis, 
mitochondrial functions and apoptosis process [145-148].  
 
1.3.2 Activation of keap1-Nrf2 –ARE pathway, Anti-oxidant role of Nrf2 signalling 
 
In normal conditions, Nrf2 is sequestered by Keap1 which is sensitive to oxidative stimuli 
owing to the presence of reactive cysteines. Keap1 is a key regulator of the Nrf2 signalling 
pathway and serves as a molecular switch to turn on and off the Nrf2-mediated antioxidant 
response [149]. 
In mild (physiological) oxidative stress, when oxidative modification of one of the Keap1 
cysteines occurs, Nrf-2 escapes from this proteolytic pathway, then translocates to the 
nucleus where it dimerizes with a small Maf protein and binds to DNA sequences of Phase 
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II antioxidant genes [150, 151]. In severe (pathological) oxidative stress, there is a 
dissociation of Keap-1 from Nrf-2 in the cytoplasm exposing Nrf2 for ubiquitination. 
Degradation of Nrf-2 will take place once it is released from Keap-1 to the cytoplasm [150-
152] as seen in Fig.13. 
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Figure 13: keap1-Nrf-2-ARE pathway 
 
Two mechanisms have been proposed for the activation of Nrf2-Keap1 pathway. First, 
Keap1 contains reactive cysteines that form protein-protein cross links following reaction 
with electrophiles leading to disruption of the Keap1-Nrf2 interaction and release of Nrf2. 
The high cysteine content of Keap1 suggested that this would be an excellent candidate 
 49
acting as a sensor for oxidative stress [150, 153]. The second mechanism involves the 
activation of protein kinase signaling pathways resulting in phosphorylation of Nrf2 and 
enhanced release of Nrf2 from Keap1 [151]. 
To date, activators of the Nrf2-ARE pathway are widely available and have proven to be 
well tolerated and have the ability to cross the blood brain barrier. Exposure to a number of 
these activators leads to dissociation of Nrf2 from Keap1, thereby rescuing Nrf2 from 
proteasomal degradation and allowing it to enter the nucleus. They include both 
endogenous activators (ROS and lipid aldehydes) and exogenous agents (heavy metals and 
electrophilic Xenobiotics) [36]. Various structurally-related plant polyphenolic compound 
activators have been used to activate Nrf2 like curcumin, caffeic acid phenyl ester, a 
tocopherol and synthetic antioxidants (ethoxyquin, OPZ, phorbol esters) [36].  
 
OPZ, 4-methyl-5-pyrazinyl-3H-1,2-dithiole-3-thione, is a chemo-preventive compound that 
counteracts the insults of ROS in an Nrf2-dependet manner, induces antioxidant protection 
(either by a mechanism involving an increase in the production of ROS, which may lead to 
an increase in antioxidant defense [105]), or disturbs the Keap1-Nrf2 complex by 
modifying cysteine thiol groups and/or via the phosphorylation of Nrf2-keap1 complex by 
protein kinases residues of keap1, ultimately leading to Nrf2 release [154, 155]. The 
liberated Nrf2 then accumulates in the nucleus and, in combination with Maf, transactivates 
the ARE of many cytoprotective genes, as well as that of Nrf2 itself. The gene families 
regulated by Nrf2 pathway include phase 2 enzymes (NQO-1, HO-1), antioxidants (SOD, 
CAT, GPx), NADPH generating enzymes and DNA repair enzymes. Overall, these 
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antioxidant genes commonly play an important role in cellular membrane protection against 
oxidative stress, DNA repair and protein damages [151] 
 
Genomic analyses indicated that gene families affected by Nrf2 provide direct antioxidant, 
increase levels of GHS synthesis, enhance NADPH synthesis, induce the recognition, repair 
and removal of damaged proteins, regulate expression of other transcription factors, growth 
factors and molecular chaperones, and inhibit cytokines-mediated inflammation [149, 151-
153, 156]. 
 
In vitro studies have established the importance of the Nrf2-regulated signalling pathway in 
the protection against oxidative stress. For example, mouse embryonic fibroblasts from 
Nrf2 deficient mice had increased sensitivity to superoxide anion relative to mouse 
embryonic fibroblasts cells from Wild Type (WT) mice [148, 150].  
 
Gong and Cederbaum demonstrated that the knockdown of Nrf2 in a variant line of HepG2 
cells, a human liver cell line exposed to increased ROS, resulted in decreased cell viability 
and failed to induce genes responsible for protection against oxidative stress [157]. 
Additionally, in a recent study, Khor et al. reported that the aggravation of DSS colitis in 
Nrf2−/− mice was associated with decreased expression of endogenous antioxidant such as 
HO-1, NQO-1 and GST and increased sensitivity to carcinogenesis [158, 159]. 
 
 
1.3.3 Anti-inflammatory role of Nrf2 signalling 
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Inflammation-mediated oxidative stress represents a potential stimulus for the activation of 
Nrf-2-regulated cytoprotective response. The evidence is overwhelming that Nrf2 plays a 
key role in cellular modulation of the inflammatory response. Nrf2 deficient mice have 
shown to exhibit increased susceptability to DSS-mediated colitis, cancer, allergen-driven 
airway inflammation mediated asthma , tobacco smoking and elastase mediated chronic 
obstractive pulmonary disease compared to WT mice [148, 159, 160]. Additionally, an 
enhanced expression of Nrf2 and decreased expression of pro-inflammatory mediators, 
such as IL-1β, IL-6 and TNF-α, were detected in the colons originating from WT but not 
mice exposed to DSS, a model of colitis [150, 158].  
 
It has been proposed that the protective effect of Nrf2 modulates inflammation by 
inhibiting the NF-κβ pathway as documented in the case of Nrf2–/– mice. As increased 
ROS levels activate an NF-κβ signalling pathway (leading to pathogenic states like 
traumatic brain injury and septic shock), Nrf2 displays ability to limit ROS levels leading to 
the inactivation of redox sensitive pro-inflammatory NF-κβ pathway, thereby maintaining 
redox homeostasis [160, 161].  
 
Severe mucosal damages as a consequence of increased infiltration of inflammatory cells, 
up-regulation of pro-inflammatory cytokine signaling and raised oxidative input, was 
detected in the colons derived from Nrf2-deficiencient mice but not WT mice during DSS-
mediated inflammatory components. These results demonstrated that the Nrf2 signaling 
pathway is a protective factor against inflammation-associated tumorigenesis and illustrates 
a potential strategy for chemoprevention of inflammation-associated carcinogenesis. Taken 
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together, these studies show that the Nrf2 signalling pathway can effectively attenuate pro-
inflammatory stimuli leading to decreased inflammation and inflammatory damage [158]. 
Many studies have provided strong evidence that Nrf2 exerts significant anti-oxidant and 
anti-inflammatory effects in protecting a variety of tissues (lung, liver, intestine) [160, 162-
164]. However; the mechanisms by which Nrf2 contributes to protection of intestinal 
epithelial cells are only partially understood. 
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2 RESEARCH  PROJECT 
2.1 Hypothesis 
 
1. Oxidative stress may affect various mitochondrial functions, including ATP 
production, Ca2+ homeostasis, cellular redox state, apoptosis and mtDNA integrity 
in intestinal epithelial cells. 
 
2. The Nrf2 pathway maintains cellular redox homeostasis in intestinal epithelial cells, 
thereby improving mitochondrial functions and cell survival. 
 
2.2 Objectives 
 
We will address the mechanisms whereby increasing the ROS generation leads to 
mitochondrial dysfunction in intestinal epithelial cells. We will also evaluate the role of 
Nrf2 as an antioxidant and anti-inflammatory agent with the capacity to maintain cellular 
redox homeostasis in intestinal epithelial cells, which ultimately results in improving 
mitochondrial functions and cell survival.  
More specifically, we will 
1. Characterize the interaction between oxidative stress and mitochondrial dysfunction in 
the Caco-2/15 cell line using the Iron-Ascorbate (FE/ASC) Oxygen radical-generating 
system, which participates in lipid peroxidation and represents a powerful tool in our hands 
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for the initiation of highly reactive hydroxyl radicals and for the down-regulation of 
endogenous antioxidants 
2. Evaluate the anti-oxidant and anti-inflammatory functions of Nrf2 in relationship with 
oxidative stress, inflammation, apoptosis, intestinal permeability and mitochondrial 
functions in Caco-2/15 cells. 
 55
3 ARTICLE 1 
1 
 
The role of oxidative stress and mitochondrial dysfunction in Crohn’s disease 
 
 
Rame Taha
1
, Ernest Seidman
2,3
, Schohraya Spahis
1 
, François Boudreau
3
, Fernand-Pierre 
Gendron
3
,
  
Jean-François Beaulieu
3
, Daniel Ménard
3
, Edgard Delvin
4
, Amre DK
5
,  Emile 
Levy
1,3
 
 
Research Centre, CHU-Sainte-Justine, Departments of 
1
Nutrition, 
4
Biochemistry and 
5
Pediatrics, Université de Montréal, Montreal (Quebec), Canada, H3T 1C5.  
2
Research Institute, McGill University, Campus MGH, C10.148.6, Montreal (Quebec), 
Canada 
3
Group on the Functional Development and Physiopathology of the Digestive Tract, Canadian 
Institute of Health Research and Department of Cellular Biology, Faculty of Medicine, 
Université de Sherbrooke, Sherbrooke, Quebec J1H 5N4, Canada 
 
Running title: oxidative stress in Crohn’s disease  
Address correspondence to: 
*Dr. Emile Levy 
Centre de Recherche 
CHU-Sainte-Justine 
3175 Côte Ste-Catherine 
Montréal, Québec, Canada H3T 1C5 
Tel.: (514) 345-4626 
Fax: (514) 345-4999 
 
2 
 
ABSTRACT 
Inflammatory bowel diseases (IBD), comprising Crohn’s disease (CD) and ulcerative colitis 
(UC), are common disorders characterized by chronic inflammation of the gastrointestinal 
tract. CD can affect any region of the gastrointestinal tract and is characterized by a 
dysregulated mucosal immune response, whereas UC appears as a condition in which the 
inflammatory response and morphological changes remain confined to the colon . No precise 
etiology has been identified for CD, and complex interactions between genetic, microbial, 
immune, and environmental risk factors are thought to underlie the pathogenesis. Very limited 
evidence is available on the mechanisms that generate the chronicity and relapsing/remitting 
nature of the disease. A key factor relevant to chronic intestinal inflammation is oxidative 
stress. Reactive oxygen species,  produced in large amount by inflammatory cells, are a major 
tissue-destructive force in most organ systems, including the gastro-intestinal tract. We have 
hypothesized that mitochondria are central to the regulation of oxidative stress and play a 
paramount role in the pathogenesis of IBD. In this review, we highlight the importance of 
mitochondria and discuss the potential mechanisms linking mitochondrial function to chronic 
inflammation in CD. 
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Abbreviations: 
ATP;  Adenosine-5'-Triphosphate 
Ca
2+
;  Calcium 
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IBD;  Inflammatory Bowel Disease 
IL;  Interleukin  
MDA;   malondialdehyde 
Mt;  Mitochondrial 
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INTRODUCTION 
Crohn’s Disease (CD) is a chronic relapsing intestinal inflammation in genetically susceptible 
individuals and is influenced by environmental factors [1]. In north America, the highest 
incidences of CD occur in Canada and the Northern United States compared to the South 
area[2].  The gap in incidence of CD in ethnic or racial groups compared with white has been 
closing with an increased incidence in African Americans and in second generation South 
Asians who have migrated to developed countries [3]. The annual incidence of CD in northern 
climates is 6-15/100.000, with a prevalence of 50-200/100.000 persons. The peak age for CD 
occur in 20-30 years and is 20%-30% more frequently in women than in men in high 
incidence areas [2, 4]. 
 
Although not associated with increased mortality, CD can cause significant morbidity. There 
has been a considerable increase in hospitalizations for CD, with stable rates of bowel 
resection surgery [5]. Recent findings from the United States reveal that the overall 
hospitalization rate for CD is 18.0 per 100.000 and contributes to disability in ~119.000 
patients per year [6].  Another important feature is that over the long-term, up to 75% of CD 
patients will require surgery [7]. The significant disease-associated morbidity exerts enormous 
economic burden and makes CD a public health issue [8, 9]. 
  
In spite of the tremendous progress in understanding the underlying mechanisms contributing 
to the chronic intestinal inflammation characteristic of CD, the key processes remain elusive 
although the implication of oxidative stress has long been promulgated. Oxidative stress in 
chronic intestinal inflammation is characterized by an imbalance between reactive oxygen 
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species (ROS) production and anti-oxidant defense [10]. Surprisingly, even if oxidative stress 
occurs in the intestinal mucosa of CD patients, limited studies have explored the response of 
mitochondria to oxidative stress in relation with key cellular regulatory processes, including 
adenosine-5’-triphosphate (ATP) production, intracellular calcium regulation, cell signaling, 
ROS generation and detoxification, and apoptosis. In this review we highlight the potential 
role of mitochondria in CD-related oxidative stress and propose several mechanisms linking 
mitochondrial dysfunction to oxidative stress and the chronic intestinal inflammation. 
 
Pathogenesis of CD 
CD is a heterogenus disorder in association with many factors such as environment, microbial 
flora , dysfunctional immune response, and genetic variables[11]. The role of environmental risk 
factors in CD is based upon epidemiological, clinical and experimental studies [12-14]. Tobacco 
smoking, particularly cigarette, is the most consistently environmental risk factor associated with 
an increased risk for CD and with a poorer prognosis, as defined by higher relapse rates, a more 
aggressive disease course and increased risk of postoperative recurrence [15]. A meta-analysis 
suggests that smokers are more than twice likely to develop CD compared to non-smokers [16]. 
Others suggested factors such as western life-style, social, occupation status, diet, psychological 
stress, hygiene, drugs, appendectomy and exposure to infections play a role in expression of CD 
[11, 17-20]. Additionally, changed dietary practices and increased hygiene have been implicated 
in the immunoregulatory defects in the intestinal mucosa, which appear to be associated with 
microbial exposure in the pathogenesis of CD[12, 18] . Increased hygiene in developed countries 
is postulated to have led to the rising incidence of CD and other autoimmune disorders [21]. In 
particular, evidence linking bacterial flora and intestinal inflammation includes the observation 
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of relatively high concentrations of bacteria in the normal distal ileum and colon, which is 
thought partly to explain the predominance of CD in these segments of the gastrointestinal tract 
[22, 23]. Noteworthy, studies in patients  or animal models  with CD have demonstrated various 
changes in the luminal flora with a link to local inflammation and immune function . At present, 
most efforts are being devoted to better understand which enteric bacteria may have a pathogenic 
potential, and why their recognition by the mucosal immune system leads to inflammation in 
CD. 
 
Genetic data have provided strong evidence for the existence of genetic determinants of 
susceptibility to CD, and it is now accepted that genes contribute to risks, may lead to a clearer 
understanding of pathogenesis, and ultimately better treatment. Several genetic loci on various 
chromosomes have been reported to be related to CD. Genome-wide associations (GWAS) 
studies have show strong association between CD and more than 30 additional genes and 
variants, such as autophagy-related 16-like 1 gene (ATG16L1), immunity-related GTPase 
family(IRGM), interleukin 23 receptor (IL23R), all of which highlight specific pathways of 
disease pathogenesis involving  intestinal flora and  immune response (TABLE 1). More 
recently, our group has confirmed the reported GWAS between the IL23R gene and CD, where 
we suggested that IL23R is also associated with pediatric-onset CD among Canadian children 
[24]. Future genetic research should focus on phenotypes, control for environmental variables, 
geographical localisation and gene-gene interactions. 
 
Inflammation in CD 
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As mentioned before, inflammation associated with CD is transmural, while inflammatory 
changes in UC involve only the intestinal mucosal and submucosal layers. In the other hand, 
inflammation in CD, is discontinuous, segmental with the presence of granulomas in all the 
gastrointestinal tract [25] . In fact, intestinal chronic inflammation is characterized by infiltration 
of neutrophils and macrophages into the intestinal mucosa, as well as the disruption of intestinal 
epithelial cells with augmentation of intestinal epithelial permeability [26]. These activated 
inflammatory cells generate reactive oxygen species (ROS), which subsequently produce 
oxidative injury in intestinal mucosa, along with a concomitant imbalance in redox status. The 
production of ROS is an important factor in the development and perpetuation of inflammation 
in CD[27]. Importantly, redox imbalance leads to generation of numerous proinflammatory 
mediators, including interleukin (IL)-1, tumour necrosis factor alpha (TNF-, IL-8 and IL-6 
[28]. These mediators can, at their turn, generate ROS and reactive nitrogen species, leading to 
vicious circle of excessive oxidative stress production. There is evidence that ROS and 
proinflammatory cytokines work synergistically as activators of transcription factors, such as, 
nuclear factor-kappaB (NF), activator protein-1, thereby modulating their activity either 
directly or indirectly by activating other signalling cascades[29, 30]. However, activation of NF-
κ has been specifically implicated in maintaining inflammation by activation of a variety of 
inflammatory genes.  NF acts as a survival signal for intestinal epithelial cells [26, 31]. 
Impaired NF-signaling in the gut epithelium initiates the primary events of intestinal 
inflammation. Recent studies showed that alterations of IkappaB kinase (IkB)/NF signaling, 
specifically in intestinal epithelial cells in vivo, cause intestinal inflammation in mice [31]. The 
importance of this transcription factor has been strengthened by the evidence that NOD2, an 
intracellular sensor of bacteria, is a positive regulator of NF-κ/IL-1β-mediated innate response 
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to bacteria challenge [22, 32]. Interestingly, Cogswell et al. have found that NF and IkB- 
are localized in the mitochondria and can negatively regulate mitochondrial gene expression in 
response to cellular TNF- stimulation [33]. This is particularly important since plays a 
significant role in CD, as  a powerful mediator of intestinal inflammation. Increased levels of 
TNF- have been found in serum, plasma, mucosa, and stool of patients with CD [34, 35]. 
Furthermore, several clincal trials have reported that anti-TNF- antibody is effective in the 
treatment of CD, verifying the importance of TNF- in the ongoing intestinal inflammation [36, 
37] .  
 
Oxidative stress in CD 
Under physiological conditions, low ROS levels constitute inter- and intra-cellular signals, 
which are vital to maintain proper cellular function. However, ROS levels are increased in 
pathophysiological conditions, and their high concentrations can oxidize nucleic acids 
(nuclear and mitochondrial DNA), lipid peroxidation and protein damage[38, 39]. Thus, 
depending on their cellular concentrations and duration, ROS can act as either beneficial or 
harmful biological agents. Free radicals interact with iron and can potentially enhance 
intestinal inflammation through the production of hydroxyl radicals via its catalytic activity in 
the fenton reaction[40]. 
 
There is growing evidence that oxidative stress leads to many biochemical changes that 
contribute to numerous chronic disorders, including CD. The intestinal mucosa is vulnerable to 
oxidative stress from exposure to ROS generated by the lumen contents such as food particles, 
metals such as iron and copper and bacterial products. Affected CD patients show a misbalance 
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between production of free radicals and antioxidant defenses[41, 42]. Some studies showed that  
immune cells of CD patients present a significant ROS increase in both activity and remission 
phases of the disease, in combination with decreased antioxidant enzymes[42, 43]. Our group has 
documented that these disturbances are often associated with malnutrition secondary to reduced 
dietary intake and malabsorption, potentially impairing essential polyunsaturated fatty acid and 
antioxidant status, as well as the composition of lipoprotein particles[44]. In addition to intestinal 
inflammation, the generation of ROS may lead to disruption of mucosal barrier function largely 
characterized by increased permeability[45, 46] .  
 
Lipid peroxidation may be estimated by the determination of malondialdehyde (MDA) 
concentration. The increased MDA levels found in plasma [44] and colonic biopsies [10] from 
CD patients provide evidence for excess lipid peroxidation reactions. Furthermore the increased 
breath ethane and pentane excretion in CD patients, which are non-invasive markers of lipid 
peroxidation, have been correlated with disease activity [47]. Using biopsies from CD patients, 
investigators could document an enhanced inflammation and oxidative stress markers along with 
a decline in antioxidant status in active CD. As the patients improved and became clinically 
stable, the oxidative parameters decreased, approaching normal values [42]. Other studies 
support these findings by demonstrating that high ROS production directly caused intestinal 
epithelial cell injury.  
 
Host defenses include antioxidants enzymes, such as catalase, glutathione (GSH), glutathione 
peroxidase (GPx), glutathione reductase (GR), glutathione-s-transferase (GsT) and superoxide 
dismutase (SOD), along with dietary antioxidants (e.g. vitamines C, E, A)[48, 49]. In general, 
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antioxidants prevent free radical-induced tissue damage by inhibiting the formation of radicals or  
promoting their decomposition. It has been suggested that the gut may be particularly sensitive to 
oxidative stress because of the relatively low concentration of endogenous antioxidant enzymes 
and the presence of high concentrations of xanthine oxidase. It has previously been shown that 
the levels and the balance between the most important antioxidants are seriously impaired within 
the intestinal mucosa from CD patients [39, 50, 51]. In active disease, some studies found an 
increase in SOD and GPx activities, whereas catalase remains constantly inhibited , suggesting 
that this enzyme is not redox-sensitive but rather a sensor of cellular proceseses[42] . 
 
Oxidative stress and mitochondrial dysfunction in CD 
The mechanisms responsible for the increase in oxidative stress in CD patients are not 
completely understood. Scientific indications stress the importance of investigating the 
association between oxidative stress and mitochondrion involvement. Mitochondria are 
multifunctional organelles involved in numerous metabolic activities, including production of 
ATP, oxidative phosphorylation, calcium (Ca
2+
) homeostasis and in the regulation of apoptosis 
pathways [52]. They have emerged as organelles that receive, integrate and transmit signals [53]. 
Mitochondria constitute a major source of free radicals in cells, resulting in oxidative stress, but 
are also targets to oxidative stress action [54, 55] . Although the molecular mechanisms 
responsible for mitochondrion-mediated disease processes are not fully elucidated yet, oxidative 
stress appears to be a pivotal player. Hence, it is apparent that mitochondrial damage may lead to 
the impairment of various aspects of tissue functioning.  
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ROS produced by the mitochondria can modify the mitochondrial (mt)DNA [56].  As a 
consequence, DNA damage results in mutations which, if not repaired, may lead to an 
increased risk of cancer [57]. Oxidative stress has been one of the risk factors that induce gut 
malignancy. The accumulation of mtDNA mutations cause the loss of mitochondrion ability to 
produce sufficient energy to meet cellular needs and serves as a trigger for mitochondrial 
dysfunction and apoptosis [58]. Mutated mtDNA may be associated with increased superoxide 
radical production, thereby leading to a vicious cycle that  progressively stimulates the rise of 
oxidative stress leads to impaired mitochondrial function[59, 60, 61]. Mitochondrial DNA is 
vulnerable to oxidative damage because it is situated much closer to the site of ROS 
generation, given that mitochondria lack protective histones and have much more reduced 
base excision repair mechanisms [62].  
 
Oxidative DNA damage was noted in plasma from CD patient and was measured by 
production of 8-hydroxy-deoxy-guanosine (8-OHdG). Plasma levels of (8-OHdG) was found 
to be increased in CD patients compared to the control [50, 51]. It has also been shown that 8-
OHdG level was significantly higher in active CD, inactive CD and CD patients in remission 
compared to control [43]. This molecule (8-OHdG), which is more specific for mtDNA, is of 
practical importance because it is easily measurable and has therefore been proposed as a 
useful marker of oxidative stress [63].  
 
Human cells have developed different repair enzymes, the most important being 8-oxo DNA 
glycosylase (OGG1) that provides protection against the effects of oxidized DNA bases and 
preferentially removes 8-OHdG opposite cytosine [64]. In  mitochondria, OGG1 is thought to 
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prevent activation of the intrinsic apoptotic pathway in response to oxidative stress by 
augmenting DNA repair mechanism [56]. Recent data provides accumulating evidence on the 
association between intestinal inflammation, oxidative stress, DNA repair enzyme OGG1 and 
carcinogenesis. OGG1
-/-
 mice developed a significantly higher number of adenocarcinomas in 
the dextran sulfate sodium-induced (DSS) colitis model compared to wild type mice [64, 65]. 
However, the OGG1 level has not been yet investigated in CD patients. Thus increase in 
mtDNA damage in CD, might modify mitochondrial function and render the intestinal cell to 
more environmental influences. This is an area worthy of further exploration.  
 
One of the functions of mitochondria is to store free Ca
2+
, a key regulator of mitochondrial 
function, that acts at several levels within the cell to stimulate ATP synthesis [66]. 
Mitochondrial may have an impact on
 
Ca
2+
 signals, removing Ca
2+
 locally
 
and modulating 
Ca
2+
 concentrations [67]. Oxidative stress caused a rapid increase in cytosolic Ca
2+
, which 
was followed by mitochondrial Ca
2+ 
loading [68]. Mitochondrial matrix Ca
2+ 
overload, at their 
turn, can lead to induced production of ROS, triggering the permeability of transition pores 
(PTP) and cytochrome c release, and leading to apoptosis [69, 70]. It has been suggested that 
PTP opening (triggered by Ca
2+
) induces a specific conformational change of complex I, 
which results in an increase of H2O2 production when electrons are provided to complex I, and 
it may also inhibit the electron pathway inside complex I [70]. ROS-mediated mitochondrial 
damage and dysregulation of Ca
2+
 homeostasis may represent several important mechanisms 
responsible for amplifying the vicious cycle leading to progressively increasing intracellular 
ROS concentrations and oxidative stress [71, 72]. Excess Ca
2+
 ions stored in mitochondria can 
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inhibit oxidative phosphorylation, which may provoke an irreversible reduction in the energy 
status, thereby initiating pathophysiological processes in certain cells [73]. 
 
The exact mechanism of mitochondrial Ca
2+ 
induced ROS generation is unclear, although it 
may involve changes in the three-dimensional conformation of the respiratory complexes [72]. 
More recent studies suggest that disruptions in intracellular Ca(2+) mobilization lead to 
increased CaM kinase II activity that may contribute to the dysmotility of colonic smooth 
muscles in murine DSS-colitis by enhancing NF-kappaB activity [74]. In addition, Di 
Sabatino A et al, have provided evidence that suppression of Ca
2+
 release may inhibit pro-
inflammatory cytokine production and dampen the increased T cell response in inflamed gut. 
Thus Ca
2+
 channel inhibitor drugs might have a major role in the therapeutic management in 
CD patients [75]. We believe that increase in mitochondrial Ca
2+
 level in combination with 
excessive ROS generation in gut epithelium is pivotal pathway in CD pathogenesis. Thus, 
calcium homoeostasis might be crucial for the maintenance of the mitochondrial function, 
which is worthy of further investigation and might provide opportunities to develop novel 
therapeutic interventions to protect cell survival. 
 
In vitro exposure to ROS, or depletion of cellular antioxidants, has been observed to result in 
apoptosis [76]. Mitochondrial apoptosis-mediated pathways rely on the permeabilization of 
mitochondrial membranes, due to oxidative stress, leading to collapse of the mitochondrial 
membrane potential, along with release of apoptogenic mitochondrial proteins (cytochrome C 
and apoptotic inducing factors) into the cytoplasm, which triggers a cascade of events, leading 
to activation of caspase 9 and downstream cleavage of caspase 3, 6 or 7 [56, 77, 78]. More 
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recent data by Catrazi et al suggest neutrophils apoptosis in CD patients and may offer a new 
target for specific drugs and therapy tools. Elucidation of proapoptotic and antiapoptotic 
mechanisms in intestinal tissue
 
could delineate potential targets
 
for intervention.[79] 
  
Limited non conclusive results have linked to mitochondrial damage to CD pathogenesis. 
Several studies suggest that stressors worsen the course of CD. Farhadi et al.  have demonstrated 
that mitochondrial damages were noted in intestinal epithelial cells and mucosal protein 
oxidation in stressed CD patients [80]. Soderholm et al. observed the presence of numerous 
swollen and irregular mitochondria in the epithelium of colonic segments from stressed rats [81]. 
In addition, O'Morain et al. showed mitochondrial damage by examination of rectal biopsies 
obtained from CD patients [82]. Finally, a recent case report on a young girl with CD disclosed 
impaired oxidative phosphorylation along with abnormalities in Complexes III and IV [83]. The 
importance of these observations is that they highlight the potential pathogenetic pathways that 
might be initiated by genetic or environmental causes of CD, which is worthy of further 
investigation and might provide opportunities to develop novel therapeutic interventions that 
improve mitochondrial function and might slow the progression of CD processe. 
 
Recent advances in molecular genetics suggest a role for mitochondrial dysfunction in the 
development of CD. Previous study, by Theiss et al. have demonstrated that prohibitin (PHB), 
a chaperone protein involved in the stabilization of mitochondrial respiratory enzymes, 
localizes in the inner mitochondrial membrane and protects against oxidative stress in 
intestinal epithelial cells. It has been also found that PHB expression is down-regulated in CD 
patients, in experimental colitis in vivo and during oxidative stress in vitro [84]. More 
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recently, Theiss et al. have shown that TNF- decreases PHB expression in intestinal 
epithelial cells and restoration of PHB expression in these cells can protect against the various 
effects of TNF-and NF on intestinal barrier function [85]. Since overexpression of PHB 
can protect against oxidative stress and inflammation. Increase in PHB levels in CD patients 
may represent a potential therapeutic strategy to prevent mitochondrial dysfunction. 
 
Mitochondrial dysfunction in CD is likely to be highly complex processe. It is becoming 
increasingly important to address the mechanisms by which the interplay between oxidative 
stress and intestinal inflammation leading to mitochondrial dysfunction, may represent a 
major role in CD pathogenesis. We propose that chronic intestinal inflammation in genetically 
susceptible hosts exposed to environmental factors triggers ROS overproduction and 
disruption of mitochondrial structure and function through mtDNA alterations, Ca
2+
 overload, 
inhibition of mitochondrial electron transport chain enzymes activity and apoptosis(Fig 1). 
Once we understand the dynamic interplay between these crucial signaling pathways, we will 
be poised to develop therapies for the mitochondrial dysfunction in this disease. 
 
Therapeutic Intervention: Antioxidants targeted to mitochondria 
One of the reasonable answer for the failure of antioxidants to show clear therapeutic effects is 
their incapacity to reach mitochondria. Currently, there is growing efforts in developing 
mechanisms for the targeted delivery of antioxidants to mitochondria [86]. More recently, 
confocal imaging studies in Caco-2 cells show that intracellular distribution of SS-19 
tetrapeptidesas antioxidant resembles that of MitoTracker, which localizes in mitochondria 
[87].  
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The involvement of mitochondrial dysfunction in a range of clinical diseases and their roles in 
cellular energy metabolism, apoptosis, Ca
2+ 
homeostasis and cell signaling has made the 
mitochondrion a target for drug delivery [88]. Hence, there is considerable interest in 
developing strategies to target small and large molecules with therapeutic potential to 
mitochondria. Several pharmacological agents are currently under investigation, including 
targeting antioxidants to mitochondria, uncoupling proteins and mitochondrial permeability 
transition pore inhibitors[89]. 
 
There are four various targeting strategies available for the selective delivery of low molecular 
weight drugs to mitochondria , including (i) targeting based on biophysical properties of 
mitochondria. (ii) targeting based on binding to mitochondrial membrane components (iii) 
targeting based on the specific mitochondrial localisation of enzymes that catalyse the release 
of drugs from prodrugs (iv) and targeting based on transporter-dependent delivery of prodrugs 
or drugs[86, 88]. 
 
The potential therapeutic applications of mitochondrial targeting include: (i) the delivery of 
antioxidants to mitochondria (ii) the targeting Bcl-2 proteins to mitochondria to trigger 
apoptosis; (iii) the delivery of drugs to mitochondria to inhibit the mitochondrial permeability 
transition and (iv) the targeting of drugs to either uncouple the electron transport chain , or 
activate the uncoupling proteins. More pre-clinical and clinical studies are necessary in order 
to evaluate the feasibility, effectiveness and toxicity of these molecules.  
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Developments of non-invasive biomarkers of mitochondrial dysfunction are in need for future 
clinical studies. Such biomarkers would assess the effectiveness of therapeutic interventions and 
the progression of the diseases.We hope that work over the next few years will indicate whether 
these compounds are effective, can decrease mitochondrial oxidative damage in diseases, and 
improve outcomes for the patients with mitochondrial impariment diseases. If our proposal is 
proved in large clinical studies, this will clear the  way to test those molecules that improve 
mitochondrial function and might slow the progression of CD. 
 
Perspective and Future Directions  
Basic research in  mitochondrial diseases related to oxidative stress has made a tremendous 
progress within
 
the past few years and will undoubtedly provide exciting new insights
 
in the 
near future. There are clearly more questions than answers in this field related to CD. In this 
respect, several issues appear to deserve further investigation: It is important to determine 
whether
 
the
 
mitochondrial dysfunction is one of the early causes rather than a terminal
 
event 
and whether mitochondrial defects result from inflammatory cytokines that inhibit 
mitochondrial respiration;  (i)  can we find mutations in mt DNA and nuclear DNA?;  (iii) 
what is the role of mitochondrial Ca
2+
 overload in the development of CD and what are the 
pro-apoptotic proteins released by mitochondria, which initiate caspase activation and 
apoptosis and whether
 
the degree of apoptosis could provide additional prognostic
 
information 
in CD patients?; (iv)  what is the molecular signal pathway capable of orchestrating the cross-
talk among mitochondria, cytosol and nucleus?;  (v) what are the specific transcription factors 
implicated?;  (vi) does intestinal microbial infection lead to mitochondrial damage?; and  (vii) 
18 
 
can we protect mitochondria damage by pharmacological inhibition, targeting antioxidants to 
mitochondria or nutritional therapy?  
Taken together, several exciting mechanisms need
 
to be tested to determine whether the 
modulation of mitochondrial dysfunction will translate
 
into new treatment approaches for CD. 
Recognition of the inducing mechanisms could
 
open up ways to improve mitochondrial 
dysfunction in intestinal tissues
 
and possibly help to define targets for future drug design.  
 
CONCLUSIONS 
Few experimental data have been gathered in the past years to support our concept that 
mitochondrial dysfunctions are more important contributors to CD development than is 
currently recognized. The detailed mechanisms by which these biochemical events cause CD 
remain to be established. The molecular genetic approaches to study CD will provide a deeper 
understanding of the CD-related alterations in the structure and function of mitochondria.  
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Table 1: Various genes involves in CD and UC pathogenesis  
 
Locus Chromosomal region CD UC     References 
IBD1 16   ++ - [90] 
IBD2 12   + + [91] 
IBD3 6   ++ ++ [92] 
IBD4 14   ++ - [91] 
IBD5 5   ++ - [93] 
IBD6 19   ++ ++ [94] 
IBD7 1   ++ ++ [95] 
IBD8 16   + NA [9696] 
IBD9 3   ++ NA [97] 
CD: Crohn’s Disease; UC: Ulcerative Colitis; IBD: Inflammatory Bowel Disease; NA: not 
available 
20 
 
Figure  1:  Proposed model of how inflammation associated with oxidative stress in 
genetic susiptable promotes the development of mitochondrial dysfunction in CD 
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ABSTRACT          
BACKGROUND: Although mitochondrial dysfunction and oxidative stress are central 
mechanisms in various pathological conditions, they have not been extensively studied in 
the gastrointestinal tract, which is known to be constantly exposed to luminal oxidants 
from ingested foods. Key among these is the simultaneous consumption of iron salts and 
ascorbic acid, which can cause oxidative damage to biomolecules. 
METHODOLOGY/PRINCIPAL FINDINGS: The objective of the present work was to 
evaluate how iron-ascorbate (FE/ASC)-mediated lipid peroxidation affects 
mitochondrion functioning in Caco-2/15 cells. Our results show that treatment of Caco-
2/15 cells with FE/ASC (0.2 mM/2 mM) (1) increased malondialdehyde levels assessed 
by HPLC; (2) reduced ATP production noted by luminescence assay; (3) provoked 
dysregulation of mitochondrial calcium homeostasis as evidenced by confocal 
fluorescence microscopy; (4) upregulated the protein expression of cytochrome C and 
apoptotic inducing factor, indicating exaggerated apoptosis; (5) affected mitochondrial 
respiratory chain complexes I, II, III and IV; (6) elicited mtDNA lesions as illustrated by 
the raised levels of 8-OHdG; (7) lowered DNA glycosylase, one of the first lines of 
defense against 8-OHdG mutagenicity; and (8) altered the gene expression and protein 
mass of mitochondrial transcription factors (mtTFA, mtTFB1, mtTFB2) without any 
effects on RNA Polymerase. The presence of the powerful antioxidant BHT (50 μM) 
prevented the occurrence of oxidative stress and most of the mitochondrial abnormalities. 
CONCLUSIONS/SIGNIFICANCE: Collectively, our findings indicate that acute 
exposure of Caco-2/15 cells to FE/ASC- catalyzed peroxidation produces harmful effects 
on mitochondrial functions and DNA integrity, which are abrogated by the powerful 
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exogenous BHT antioxidant. Functional derangements of mitochondria may have 
implications in oxidative stress-related disorders such as inflammatory bowel diseases. 
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INTRODUCTION 
Reactive Oxygen Species (ROS) are by-products of normal aerobic metabolism and are now 
considered to be important signaling molecules that play a role in gene expression, cell 
growth and survival as well as oxygen sensing in various cell types [1,2]. The generation of 
ROS by a cascade of reactions is efficiently blocked by various endogenous antioxidants to 
overcome their potentially injurious actions [2,3]. However, excessive formation of ROS 
leads to lasting oxidative stress, characterized by an imbalance between oxidant-producing 
systems and antioxidant defense mechanisms, which can trigger cell damage by oxidizing 
macromolecular structures (lipids, proteins and DNA) and modifying their biological 
functions that ultimately causes cell death [4]. Thus, depending on their cell concentrations, 
ROS can act as either beneficial or harmful biological agents.  
The gastrointestinal tract is frequently exposed to noxious stimuli that may cause 
oxidative stress and injury. In fact, oxygen free radicals are generated both in the lumen 
and in the intestinal mucosa. Intraluminal pro-oxidants from ingested nutrients, such as 
alcohol, cholesterol oxides or iron salts and ascorbic acid, frequently consumed together 
in multiple-vitamin preparations or ingested foods, can build a pro-oxidant milieu [5–7]. 
Moreover, local microbes or infections, ischemia/reperfusion, gastric acid production and 
non-steroidal anti-inflammatory drugs may promote the formation of reactive radicals [8–
10]. In addition, the influx of leukocytes, neutrophils and monocytes (associated with 
inflammation) can produce further ROS
 
via respiratory burst enzymes as well as those 
involved in prostaglandin
 
and leukotriene metabolism [11]. Clearly, significant oxidative 
stress has been said to be always associated with mucosal erosions and a causative role in 
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a variety of gastrointestinal diseases such as Crohn’s disease and ulcerative colitis [12–
14].  
Despite the frequent occurrence of oxidative stress in the gastrointestinal tract and its 
involvement in the initiation and propagation of the chronic inflammatory response in 
chronic bowel diseases [15], little is known about mitochondrion response even though 
this special organelle is both a major source of oxidants and a target for their damaging 
effects [16]. We have hypothesized that oxidative stress may affect various mitochondrial 
functions, including ATP production, calcium (Ca
2+
) homeostasis, cellular redox state 
regulation, apoptosis, as well as mtDNA integrity [17,18]. Therefore, the specific aim of 
the present study was to characterize the interplay between oxidative stress and 
mitochondrial dysfunction in the Caco-2/15 cell line using the iron-ascorbate (FE/ASC) 
oxygen radical-generating system, which participates in lipid peroxidation in 
inflammatory bowel diseases (IBD) and represents a powerful tool in our hands for the 
initiation of highly reactive
 
hydroxyl radicals and for the down-regulation of endogenous 
antioxidants [19–26].  
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MATERIALS AND METHODS 
Caco-2/15 Cell Cultures 
The colon carcinoma cell line, Caco-2/15 (ATCC, Rockville, MD), was cultured at 
subconfluent stages in MEM (GIBCO-BRL, Grand Island, NY) containing 1% penicillin-
streptomycin and 1% MEM non-essential amino acids (GIBCO-BRL) and supplemented 
with 10% decomplemented fetal bovine serum (FBS) (Flow, McLean, VA) as described 
previously [27]. Briefly, Caco-2/15 cells (passage 20-30) were maintained in T-75-cm2 flasks 
(Corning Glass Works, Corning, NY). Cultures cells were split (1:6) when they reached 90% 
confluence by use of 0.05% trypsin-0.5 mM EDTA (GIBCO-BRL). For individual 
experiments, cells were plated at a density of 1x10
6
 cells/well on 24.5 mm polyester 
Transwell filter inserts with 0.4-m pores (Coster, Cambridge, MA) in MEM supplemented 
with 5% FBS. Cells were cultured for 21 days post confluence, at which the Caco-2/15 cells 
are highly differentiated and appropriate for lipid synthesis and metabolism. The medium 
was refreshed every second day. To determine the implication of oxidative stress per se in 
alterations in mitochondrial functions, Caco-2/15 cells were incubated with FE/ASC (0.2 
mM/2 mM) for 6 h alone and/or with the antioxidant butylated hydoxytoluene (BHT) (2,6-di-
t-butyl-p-cresol, Sigma, St-Louis, MA)
 
(50 μM). Caco-2/15 cells were divided into four 
groups: control (without any addition), oxidative (FE/ASC), antioxidant (BHT), oxidative 
and antioxidant (FE/ASC + BHT). 
Lipid Peroxidation  
Caco-2/15 cells were cultured in the presence or absence of (0.2 mM/2 mM) FE/ASC added 
to the medium. Incubation periods were terminated with 50 µM BHT to measure 
malondialdehyde (MDA). The level of MDA formed during the oxidative reaction was 
 7 
determined by HPLC, as previously described [19]. Briefly, proteins were first precipitated 
with a 10% sodium tungstate (Na2WO 4) (Aldrich, Milwaukee, WI) solution. The protein-free 
supernatants were then reacted with an equivalent volume of 0.5% (wt/vol) thiobarbituric 
acid solution (TBA; Sigma) at 90ºC for 60 min. After cooling to room temperature, the pink 
chromogene [(TBA) 2-MDA] was extracted with 1-butanol and dried over a stream of 
nitrogen at 37ºC. The dry extract was then resuspended in a potassium dehydrogen phosphate 
(KH2PO4)/methanol mobile phase (70; 30, pH 7.0) before MDA determination by HPLC 
with fluorescence detection.  
Assessment of Intracellular ATP 
Intracellular ATP was measured by luciferase driven bioluminescence using ATP 
Bioluminescence Assay Kit from (Calbiochem, EMD Chemicals, Inc. Gibbstown, NJ) as 
reported previously [28]. Values were then normalized further with regard to the protein 
content of the respective sample. All Caco-2/15 culture cells were performed in duplicate.  
Calcium Measurements by Confocal 
For mitochondrial Ca
2+
 monitoring, Caco-2/15 cells were trypsinized, transferred
 
from cell 
culture flasks to 8-well chamber slides (Lab-Tek
TM
 Nunc, Rochester, NY) at a density of 
2,5x10
4
 cells in 500 μl of cell culture medium. After a period of three days, cells were serum-
starved and incubated with FE/ASC and/or BHT as described above. Cells were rinsed twice 
in serum-free culture medium and loaded with a mixture of 5 μM Rhod-2/AM (Molecular 
Probes, Eugene, OR), a fluorescent probe specific for mitochondrial Ca
2+
, with 0,01% 
pluronic acid for 30 min at 37ºC as described previously [29–31]. Medium was removed, 
replaced with dye-free culture medium and incubated for an additional 60 minutes at 37ºC.  
Thereafter, 1 μl of the fluorescent mitochondria-specific dye MitoTrackerTM (green 
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fluorescence, Molecular Probes) was added to each well at the last 30 min of incubation. 
Cells were visualized using an inverted laser-scanning confocal microscope equipped with a 
40X objective (LSM 510, Zeiss). Excitation wavelength was 488 nm and fluorescence 
emission was recorded at 543 nm (for Rhod-2) and 516 nm (for MitoTracker
TM
). Six to eight 
fluorescence
 
images were randomly chosen in selected microscopic fields. Fluorescence 
intensity was quantified using the Image J software (http://rsb.info.nih.gov/ij).  
Mitochondrial Preparations 
Mitochondria were isolated using standard differential centrifugation
 
techniques [32]. Briefly, 
Caco-2/15 cells were treated with (0.2 mM/2 mM) FE/ASC and/or (50 μM) BHT for 6 h at 
37°C. Cells were homogenized with a glass pestle Dounce homogenizer in a buffer 
containing 210 mM mannitol, 70 mM sucrose,
 
1 mM EGTA, 0.5% fatty acid-free bovine 
serum albumin, and 5 mM HEPES, pH 7.2. The homogenate
 
was centrifuged at 1000 x g for 
10 min at 4°C. The supernatant was then collected and centrifuged at 10000 x g for 10 min to 
obtain the pellets containing mitochondria. The pellets
 
were used immediately or stored at –
80°C. The protein contents of mitochondrial suspension were determined by the Bradford 
assay (BioRad, Mississauga, ON) with BSA as a standard. 
Evaluation of 8-hydroxy -2-deoxyguanosine  
Oxidative DNA damage in whole Caco-2/15 cells, nuclei and mitochondria was 
evaluated by assessing 8-hydroxy -2-deoxyguanosine (8-OHdG) with high-sensitivity 
competitive ELISA assays performed with a commercial kit
 
from Genox Corporation 
(Baltimore, USA). Briefly,
 
8-OHdG antibody plus sample DNA were added to a 96-well 
plate
 
percolated with 8-OHdG and incubated overnight at 4°C. After
 
the plate was 
washed, horseradish peroxidase–conjugated secondary antibody was added for 1 h at 
 9 
room temperature.
 
After washing, 3,3',5,5'-tetramethylbenzidine was added and
 
incubated 
for 15 min at room temperature in the dark. The
 
reaction was terminated by the addition 
of phosphoric acid,
 
and absorbance was measured at 450 nm. All assays were performed
 
in duplicate. Negative controls and 8-OHdG standards (0.125–10 ng/mL) were included 
in the assay. The average concentration
 
of 8-OHdG was calculated
 
for each sample based 
on the standard curve.  
Mitochondrial Enzyme Assays 
The activities of respiratory chain complexes were
 
assayed as previously described in 
detail [32–34]. Briefly, 20-30 μg of mitochondrial protein were used for each complex 
every 30 sec for 5 min. The activity of complex I (NADH: ubiquinone oxidoreductase) 
was measured by monitoring the reduction of decylubiquinone. Complex II 
(succinate:ubiquinone oxidoreductase) activity was examined by monitoring the 
reduction of dichloroindophenol when coupled to complex II-catalyzed reduction of 
decylubiquinone. Complex III (ubiquinol:ferricytochrome C oxidoreductase) activity was 
assayed using oxidized cytochrome C. The activity of complex IV (cytochrome C 
oxidase) was determined by oxidation of reduced cytochrome C. Enzyme activities were 
expressed in nanomoles of substrate used per minute per milligram of protein. Enzyme 
assays for all complexes were performed in duplicate in mitochondrial fraction of Caco-
2/15 cell line. Complex I, II, III, IV chemicals were purchased from Sigma Chemical, St 
Louis, MO. 
Western Blots 
To assess the protein mass of mitochondrial transcription factors (mt TF): mtTFA, 
mtTFB1, mtTFB2 and POLRMT, as well as 8-oxoG-DNA glycosylase (OGG1), 
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apoptosis-inducing factor (AIF) and cytochrome C, Caco-2/15 cells were homogenized 
and adequately prepared for Western
 
blotting as described previously [22,23,27,35–39]. 
The Bradford assay (Bio-Rad)
 
was used to estimate protein concentration. Proteins were 
denatured
 in sample buffer containing SDS and β-mercaptoethanol, separated on a 4–20% 
gradient SDS-PAGE and electroblotted
 
onto nitrocellulose membranes. Nonspecific 
binding sites of
 
the membranes were blocked with defatted milk proteins followed
 
by the 
addition of primary antibodies directed against the different proteins.
 
The relative amount 
of primary antibody was detected with species-specific
 
horseradish peroxidase-
conjugated secondary antibody. Even though
 
identical protein amounts of tissue 
homogenates were applied,
 the β-actin protein was used to confirm equal loading on SDS-
PAGE (results not shown). Blots were developed and the mass
 
of proteins was 
quantitated using an HP Scanjet scanner equipped
 
with a transparency adapter and 
software. Rabbit polyclonal mtTFA Ab was obtained from Santa Cruz Biotechnology 
Santa Cruz, CA; rabbit polyclonal POLRMT from Abcam, Cambridge, MA; and mouse 
polyclonal mtTFB1 and mtTFB2 Ab, rabbit polyclonal OGG1 Ab, rabbit polyclonal AIF 
Ab, and mouse monoclonal cytochrome C Ab from Novus Biologicals, Inc.  
RT-PCR 
Experiments for mRNA quantification as well as for GAPDH (as a housekeeping gene) were 
performed in Caco2/15 cells using the UNO II thermocycler (Biometra) as reported 
previously [35,40]. Approximately 30-40 cycles of amplification were used at 95ºC for 30 s, 
58ºC for 30 s, and 72ºC
 
for 30 s. Amplicons were visualized on standard ethidium bromide-
stained agarose gels. Under these experimental conditions related to RT-PCR, the cycles for 
mtTFA, mtTFB1, mtTFB2, POLRMT, OGG1 and GAPDH were 31, 31,35,31,31, and 30, 
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respectively corresponding to the linear portion of the exponential phase. Fold induction and 
quantification were determined with the software UN-SCAN-IT gel 6.1.  
Primers Used 
GAPDH (F- AGAAGGCTGGGGCTCATT/R-GGGCCATCCACAGTCTTCT) 
H-OGG1 (F-GGGGATTCACAAGGTGAAGA/R-GTAAGCTGGCTTGCATCACA) 
POLRMT (F-CATCACCTACACCCACAACG/R-GTGCACAGAGACGAAGGTCA) 
H-mtTFB2 (F-GTCGCTTTTGCATTTTAGGG/R-GCTGTCCAAGGAACTGCTTC) 
h-mtTFB1 (F-CTCCTGGACTTGAGGCTGAC/R-TTCTCAGTTTCCCAGGTGCT) 
h-mtTFA (F-GGGTTCCAGTTGTGATTGCT/R-TGGACAACTTGCCAAGACAG) 
Statistical Analyses 
Statistical analyses of data were performed with Prism 4.03 software (GraphPad Software). 
All values were expressed as the mean ± SEM. The data were evaluated by ANOVA, where 
appropriate, and the differences between the means were assessed using the Bonferroni’s 
multiple comparison test. A p-value of less than 0.05 was considered to be significant 
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RESULTS 
MDA Generation after Iron-Ascorbate Exposure 
Before evaluating the role of oxidative stress on mitochondrial function, we evaluated the 
effectiveness of FE/ASC in initiating lipid peroxidation after incubation with Caco-2/15 
cells. At the end
 
of a 6-h culture period, the degree of lipid peroxidation was
 
determined 
by measuring MDA in cells. As illustrated
 
in Figure 1, FE/ASC induced a significant 
increase in MDA levels above baseline values compared with control cells. The 
concentration of MDA was 4-fold higher in cells supplemented with FE/ASC compared 
with untreated cells. Pre-incubation with the strong antioxidant BHT markedly 
suppressed the production
 
of MDA, providing direct evidence for the ability of the 
FE/ASC
 
system to provoke profound lipid peroxidation. 
Effect of FE/ASC on Cellular ATP Content  
The main function of the mitochondrion is the production of energy in the form of ATP via 
oxidative phosphorylation and oxygen consumption. We therefore assessed the amount of 
ATP levels in Caco-2/15 cells exposed to the FE/ASC
 
oxygen radical-generating system. As 
noted in Figure 2, the administration of FE/ASC led to a four-fold reduction compared with 
untreated cells. Moreover, pre-incubation with BHT at a concentration
 
of 0.5 mM resulted in 
a trend of ATP normalization. 
Oxidative Phosphorylation Activity 
Since mitochondrial oxidative phosphorylation (OXPHOS) is fundamental to all aspects 
of cell life under aerobic conditions, we evaluated its activity during oxidative stress. The 
enzymatic activity related to complexes I, II, III, and IV was performed on mitochondrial 
fraction prepared from Caco-2/15 cells. Our findings documented a significant decrease 
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in the specific activities of complex I, II, III and IV following FE/ASC treatment (Figure 
3). Pre-incubation with BHT abrogated the decline in the OXPHOS enzymatic activities. 
Changes in Mitochondrial Calcium Induced by Iron-Ascorbate in Caco-2/15 Cells 
We next tested whether FE/ASC caused a change in mitochondrial Ca
2+
 in Caco-2/15 
cells using the positively charged and cell permeant Ca
2+
 indicator, Rhod-2/AM, which 
accumulates predominantly in the negatively charged matrix of the mitochondria. The 
dye Mitotracker
TM
 was used to confirm the mitochondrial localization of Rhod-2. As 
presented in Figure 4D, FE/ASC treatment of Caco-2/15 cells induced an increase in 
Rhod-2 fluorescence that appears predominantly located in the mitochondria as 
demonstrated by the yellow spots of strong intensity found in the merged image (Figure 
4F). In contrast, the distribution pattern of colocalized Rhod-2 and Mitotracker
TM
 
observed in control cells revealed spots of less intensity characterized by a more diffuse 
distribution (Figure 4E). Quantification of Rhod-2 fluorescence intensity is shown in 
Figure 5. Cells exhibited an increase in Rhod-2 fluorescence after FE/ASC treatment 
whereas pre-incubation with BHT restored fluorescence intensity to control level.  
AIF and Cytochrome C Protein Expression 
AIF is normally located in the inter-membrane space of mitochondria and is involved in 
initiating a caspase-independent pathway of apoptosis by causing DNA fragmentation and 
chromatin condensation. Furthermore, when cell death is triggered by an apoptotic stimulus, 
cytochrome C is released into the cytosol, and contributes to the caspase-dependent pathway 
of apoptosis. Western blot analysis revealed a marked (P < 0.001) increase in the level of AIF 
and cytochrome C protein mass in Caco-2/15 cells following FE/ASC compared with 
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controls (Figures 6). Pre-incubation with BHT before the addition of FE/ASC prevented the 
rise in AIF and cytochrome C protein mass. 
Quantification of Oxidative DNA Damage in Caco-2/15 
ELISA for 8-OHdG, a recognized marker of oxidative DNA damage,
 
was used to quantify 
oxidative DNA damage in Caco-2/15 cells. Figure 7
 
shows the average concentration of 8-
OHdG detected in the control and experimental groups. Results clearly
 
indicate that the level 
of oxidative DNA damage in mitochondria was significantly (P < 0.001) higher in
 
Caco-2/15 
exposed to FE/ASC-mediated lipid peroxidation (Figure 7A). The oxidative DNA damage 
was attenuated after pre-incubation with BHT. On the other hand, no significant changes 
were noted in the homogenate or nucleus (Figure 7B and 7C). 
OGG1 Repair Enzyme Level 
In mitochondria, the base excision repair pathway is primarily responsible for removing 8-
OHdG from DNA [41]. In humans, 8-oxodG is repaired by 8-oxoguanine DNA glycosylase 
(OGG1), an enzyme that recognizes and hydrolyzes the aberrant base from the DNA 
backbone. We, therefore, examined its gene expression and protein mass in Caco-2/15 cells. 
As well illustrated in Figure 8, treatment with FE/ASC resulted in a significant (P < 0.001) 
reduction of OGG1 mRNA and protein mass compared with controls. However, pre-
incubation of Caco-2/15 cells with BHT prevented the decline in OGG1 expression. 
Mitochondrial Transcription Factors 
Human mitochondrial transcription requires bacteriophage-related RNA polymerase, 
POLRMT, mtDNA-binding protein, h-mtTFA/TFAM, and two transcription 
factors/rRNA methyltransferases, h-mtTFB1 and h-mtTFB2. These crucial proteins define 
mitochondrial biogenesis and gene expression that together likely fine-tune mitochondrial 
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functions. Given the deleterious effects of FE/ASC, it was mandatory to explore how 
oxidative stress modulates the core protein components required for mitochondrial 
transcription. PCR and Western Blot analyses showed a significant (P < 0.01) increase in 
mtTFA, mtTFB1 and mtTFB2 gene expression (Figure 9A) and protein mass (Figure 9B) 
without any changes in POLRMT in Caco-2/15 cells treated with FE/ASC compared with 
controls. Pre-incubation with BHT attenuated the modifications of those transcription 
factors. 
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DISCUSSION 
The Caco-2/15 cell line has been used to examine a variety of intestinal functions. This 
intestinal model exhibits many of the features of small intestinal epithelial cells. We 
employed the FE/ASC
 
oxygen radical-generating system to determine how oxidative stress 
modulates mitochondrial DNA integrity and function in Caco-2/15 cells [20]. Our results 
show for the first time that FE/ASC can induce lipid peroxidation accompanied by ATP 
depletion, mitochondrial transport chain complex inhibition, mitochondrial Ca
2+
 overload, 
cell apoptosis, mitochondrial DNA lesions and mitochondrial transcription factors 
alterations. 
Iron is the most abundant transition metal in mammalian cells
 
and is essential for the 
physiological function of multiple proteins [42]. However, excess or non-protein-bound 
(labile) iron can be
 
detrimental because it can initiate oxygen radical formation and promote 
ROS [43]. Therefore, iron may cause oxidative damage to biological macromolecules and 
alter the intracellular redox environment, thereby affecting
 
redox-sensitive cell signaling 
pathways and transcription factors [44,45]. Although the mechanisms underlying the 
cytotoxicity of iron in different organs are not fully delineated, many reports have pointed to 
the participation of iron-mediated peroxidation in numerous pathological states, including 
atherosclerosis [46,47], cancer [48,49], ischemia-reperfusion injury [50], IBD [51], and 
conditions of iron overload [52]. Several laboratories [19–21,23–26,52–54] have shown the 
ability of iron to initiate strong lipid peroxidation, whereas ascorbic acid can amplify the 
oxidative potential of iron by promoting metal ion-induced lipid peroxidation. The data 
presented here clearly indicate that the FE/ASC system functioned as a producer of lipid 
peroxidation and, at the same time, altered the DNA integrity and the function of 
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mitochondria. It is noteworthy that the iron dose used in the current study is comparable with 
normal iron concentration in the gut [11]. The deteriorations resulting from the exposure of 
Caco-2/15 cells to FE/ASC are probably attributable to oxidative stress, because the addition 
of the BHT antioxidant simultaneously prevented the occurrence of lipid peroxidation and 
improved the cellular processes of mitochondrial integrity and functions. BHT was selected
 
as an antioxidant because
 
it represents a powerful agent inhibiting iron-mediated
 
oxidative 
stress and does not have any toxic effects on Caco-2/15 cell culture [21].  
Previous reports observed that an accumulation of peroxidation products in mitochondria 
leads to a decrease in ATP production and compromises the maintenance of cellular 
homeostasis [55]. In this study, incubation of Caco-2/15 cells with FE/ASC induced a marked 
decrease in ATP levels. Our data are consistent with previous investigations showing that 
ATP decreased in the HT-29 intestinal cell-line after oxidative injury by hydrogen peroxide 
[56]. The fall in ATP synthesis is probably related to the low mitochondrial metabolic 
activity resulting from the FE/ASC-mediated lipid peroxidation. In fact, electron movement 
through complexes I, II, III, and IV enables movement of hydrogen ions across the inner 
membrane into the inter-membrane space creating an electrochemical gradient, which is 
harnessed into ATP production by ATP synthase in complex V. We reasonably propose that 
mitochondrial damage from ROS may lead to a degradation in the efficiency of the 
mitochondrial respiratory chain enzymes and hence a decline in ATP production. The 
impairment of mitochondrial
 
complex I, II, III and
 
IV activity noted in our experiments may 
be attributable to ROS-induced cardiolipin
 
damage that has recently been reported in 
ischemia/reperfusion rat heart, which ultimately
 
led to a decrease in oxidative 
phosphorylation [57,58]. The phospholipid cardiolipin is found almost exclusively in the 
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inner mitochondrial membrane where it promotes the optimal function of numerous enzymes 
involved in mitochondrial energy metabolism. Finally, inactivation of mitochondrial electron 
transport chain enzymes and/or ATP-synthase may account for the ATP depletion triggered 
by the administration of FE/ASC to Caco-2/15 cells.  
On top of its ATP generation ability, mitochondria also play a part in modulating the 
amplitude and spatiotemporal organization of Ca
2+
 signals through rapidly accumulating and 
releasing Ca
2+
 [59,60]. Indeed, intracellular Ca2+ plays a key role in cellular metabolism. 
However, excessive mitochondrial Ca
2+
 overload can trigger ROS overproduction, 
mitochondrial membrane depolarization and ATP production inhibition, all hallmark events 
of mitochondrial dysfunction clearly observed in the present work. Additionally, these 
defective processes may eventually lead to apoptosis [59,60], which was also documented in 
our studies. In particular, mitochondrial Ca
2+
 overload can favor cardiolipin peroxidation, 
thereby affecting mitochondrial permeability transition, inducing AIF and cytochrome C 
release, and culminating in mitochondrial dysfunction and apoptosis [61,62]. Therefore, tools 
capable of minimizing mitochondrial Ca
2+ 
overload would decrease mitochondrial ROS 
accumulation and improve mitochondrial energy production, which may impact on 
mitochondrial-oxidative mediated diseases.  
The core human mitochondrial transcription machinery comprises a single subunit 
bacteriophage-related RNA polymerase (POLRMT), mtTFA, and two transcriptional co-
activator proteins, h-mtTFB1 and h-mtTFB2. Both factors seem to interact directly with 
POLRMT forming a heterodimer that, in addition to mtTFA, is required for the accurate 
initiation on both H1 and L promoters [63]. The main function of mtTFA is the maintenance 
of mtDNA replication and transcription during mitochondria biogenesis [64]. In our study, 
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we observed that mtTFA, mtTFB1, mtTFB2 transcriptional level and protein mass were 
augmented in the presence of Fe/ASC with no marked difference for POLRMT. Currently, 
we do not know whether the upregulation of mtTFA, mtTFB1, and mtTFB2 in our 
experiments represent a compensatory mechanism in response to oxidative stress-related 
reduction in energy metabolism such as defective electron transport chain, incomplete 
mitochondrion biogenesis or accelerated apoptosis. Accordingly, mtTFA was found 
upregulated in response to lipopolysaccharide-induced oxidative damage to mitochondria, 
presumably to enhance mtDNA levels and OXPHOS activity [65]. Furthermore, over-
expression of human TFB2M in HeLa cells induced an increase in TFB1M mRNA levels and 
protein expression [66], suggesting the existence of a retrograde signaling pathway from 
mitochondria to the nucleus, which precisely regulates the expression of these related factors. 
Further investigation is needed to examine these important aspects.  
In the present study, FE/ASC raised 8-OHdG that represents one of the most frequently 
generated oxidative base lesions within DNA, owing to guanine, the lowest redox potential 
among the nucleic acid bases formed in pathological conditions [67]. Similarly, the double 
immunofluorescence technique revealed that oxidative DNA damage is induced in colon 
epithelial cells of the IBD mouse model [68]. Furthermore, nuclei were not affected by 
FE/ASC-mediated oxidative stress, which confirms that mtDNA is more vulnerable than 
nuclear DNA to oxidative damage given that it is situated much closer to the site of ROS 
generation and that mitochondria lack protective histones and far fewer mechanisms that 
prevent reduced base excision repair activity than DNA from nuclei [69]. Our findings 
confirm that oxidative DNA damage is one of the most common threats to mitochondrial 
genome stability.  
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OGG1 is the DNA repair enzyme that recognizes and excises 8-oxodG [70]. The present 
study shows that incubation of Caco-2/15 with FE/ASC resulted in a marked decrease in 
OGG1 transcript level and protein mass. Deficiency in DNA repair enzyme OGG1 has likely 
important functional consequences, compromising the ability of cells to repair DNA. 
Therefore, intestinal epithelial cells are as sensitive to lipid peroxidation as other cell types, 
including kidney cortex cells that accumulate 8-OHdG mainly in the mtDNA and to a lesser 
extent in nuclear DNA under diabetic conditions [71]. We believe that mtDNA damage is 
linked to the numerous abnormal processes noted in our study, including ATP generation, 
Ca
2+
 homeostasis and release of signals for cell death.  
In summary, the FE/ASC system in Caco-2/15 appeared to be very effective in promoting 
lipid peroxidation and, at the same time, altering the mitochondrial function. This 
mitochondrial dysfunction is probably related to oxidative stress, because
 
the addition of 
antioxidants prevented the
 
occurrence of lipid peroxidation and improved the mitochondrial 
function in terms of ATP production, Ca
2+
 homeostasis and apoptotic protein expression. The 
pattern of our results
 
using the Caco-2/15 cell line may prove useful in elucidating the 
molecular
 
mechanisms implicated in IBD. Overall, our data suggest that oxidative-
mitochondrial dysfunction is not mediated by a single mechanism, but that it may instead be 
a consequence of multiple vicious circles organized within a complex functional network. 
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FIGURE LEGENDS 
Figure 1 Malondialdehyde (MDA) concentrations in Caco-2/15 cells challenged 
with iron/ascorbate and/or BHT 
At 21 days of differentiation, cells were exposed to (0.2 mM/2 mM) FE/ASC, 
(50 μM) BHT or both for 6 h at 37°C. Oxidative stress was assessed by 
measuring MDA as an index of lipid peroxidation. Values are means ± SEM 
for three independent experiments. 
*
P < 0.05 
Figure 2 ATP Levels in Caco-2/15 cells exposed to iron/ascorbate in the presence 
or absence of BHT 
Caco-2/15 cells were grown on 96-well plates and, after 21 days post 
confluence, they were treated with (0.2 mM/2 mM) FE/ASC and/or (50 μM) 
BHT for 6 h at 37°C. ATP levels were measured with a bioluminescence 
assay and corrected for intracellular protein concentrations. Values are 
expressed as ng of ATP per g of cellular protein and represent the means ± 
SEM for three independent experiments.
*
P < 0.001 
Figure 3 Effect of iron/ascorbate and/or BHT treatment on enzymatic activities of 
mitochondrial respiratory chain complexes in Caco-2/15 cells  
Enzyme activities of mitochondrial respiratory chain complexes I, II, III, IV 
were measured by spectrophotometric assays in mitochondrial samples in 
Caco-2/15 cells treated with (0.2 mM/2 mM) FE/ASC and/or (50 μM) BHT 
for 6 h at 37°C. Enzyme activities are expressed as nmol/ min/ mg protein. 
Each value represents the mean ± SEM for 3 separate experiments performed 
in duplicate. *P < 0.05 vs. controls.  
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Figure 4 Influence of oxidative stress on mitochondrial calcium homeostasis in 
Caco-2/15 cells 
Representative fluorescence images of control and FE/ASC-treated Caco-2/15 
cells loaded with the mitochondrial dye MitoTracker
TM
 (A, B) and the 
mitochondrial Ca
2+
 indicator Rhod-2 (C, D). Merged images (E, F) indicate 
colocalization of the two dyes in the mitochondria. Mitochondrial Ca
2+
 
accumulation is visible upon oxidative stress (arrow). Scale bar-10 μm. 
Figure 5 Quantification of Rhod-2 fluorescence intensity in Caco-2/15 Cells 
subjected to iron/ascorbate and/or BHT treatment 
Caco-2/15 cells pretreated for 6 h with (0.2 mM/2 mM) Fe/ASC and/or (50 
μM) BHT were loaded with 5 M of Rhod-2 AM for 30 minutes at 37oC. 
Fluorescence intensity was quantified by image analysis as described in 
Material and Methods. Six to eight fluorescence
 
images from three 
independent experiments were randomly chosen. Results were calculated by 
dividing the pixel intensity by the area of the spot (μm. Data illustrated 
represent the means ± SEM. 
*
P < 0.001 
Figure 6 Cytochrome C and AIF expression levels in Caco-2/15 Cells treated with 
iron/ascorbate and/or BHT 
Caco-2/15 cells were incubated with (0.2mM/2 mM) FE/ASC and/or (50 μM) 
BHT for 6 h at 37°C. Gene and protein expression were determined by RT-
PCR and Western blotting, respectively. Values are expressed as means ± 
SEM for three independent experiments.
 *
P < 0.001 
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Figure 7 Influence of iron/ascorbate treatment in the presence of absence of BHT 
on 8-hydroxy -2-deoxyguanosine level in Caco-2/15 cells 
The levels of 8-hydroxy -2-deoxyguanosine (8-OHdG) were measured by 
ELISA kit assay in (A) mitochondrial, (B) homogenate and (C) nucleus 
samples in Caco-2/15 cells treated with (0.2 mM/2 mM) FE/ASC and/or (50 
μM) BHT for 6 h at 37°C. Values are means ± SEM for three independent 
experiments. 
*
P < 0.001 
Figure 8 Effect of iron/ascorbate and/or BHT treatment on 8-oxoG-DNA 
Glycosylase levels in Caco-2/15 cells 
Caco-2/15 cells were incubated with (0.2mM/2 mM) FE/ASC and/or (50 μM) 
BHT for 6 h at 37°C to determine the effects of oxidative stress on 8-oxoG-
DNA glycosylase (OGG1) gene expression (A) and protein mass (B). Values 
are expressed as means ± SEM for three independent experiments carried out 
in triplicate. 
*
P < 0.001 
Figure 9 Effect of iron/ascorbate and/or BHT treatment on gene and protein 
expression of mitochondrial transcription factors in Caco-2/15 cells 
Effects of (0.2mM/2 mM) FE/ASC, (50 μM) BHT or both for 6 h at 37°C on 
gene expression (A) and protein mass (B) of mtTFA, mtTB1, mtTB2, 
POLRMT. A GAPDH cDNA probe was used as a control for RNA loading; 
β-actin was used as loading control protein. Data originated from three 
independent experiments. Values are expressed as means ± SEM.
 *
P < 0.01 
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Abstract 
Oxidative stress can lead to multiple cellular and mitochondrial dysfunctions along with 
marked inflammation, which in turn can mediate most chronic inflammatory bowel diseases.  
Although nuclear-factor-erythroid-2-related factor (Nrf2) is a sensitive transcription factor that 
orchestrates the expression of a battery of antioxidant and detoxification genes, limited 
information is available on its role in the gastrointestinal tract. The objectives of this study 
were to evaluate the antioxidant and anti-inflammatory functions of Nrf2 as well as its 
implication in mitochondrial functions in intestinal epithelial cells. To this end, the Nrf2 gene 
was knocked down by transfecting Caco-2/15 cells with a pGFP-RS lentiviral vector 
containing shRNA against Nrf2 and cells were then treated with various concentrations of 
iron/ascorbate (Fe/Asc) to induce mild to severe oxidative stress. Inactivation of Nrf2 resulted 
in increased lipid peroxidation as demonstrated by raised malondialdehyde levels. 
Concomitantly, a significant reduction was noted in antioxidant enzymes, including catalase, 
glutathion peroxidase and superoxide dismutase. This loss of redox homeostasis led to an 
augmentation in inflammatory mediators such as tumor necrosis factor alpha and nuclear 
factor-kappa B. Interestingly, Nrf2 silencing or oxidative stress provoked loss of cell junctional 
sealing as reflected by low occludin expression. Moreover, isolation of mitochondria revealed 
a decline in ATP production, respiratory complex (I, II, III, IV) activity, Bcl2 anti-apoptotic 
factor and PGC-1α, a crucial regulator of mitochondrial genesis, energetics and functions. In 
conclusion, Nrf2 appears to be an active actor in cytoprotection against oxidative stress and 
inflammation as well as mitochondrial functional integrity. 
Keywords: Oxidative stress, inflammation, antioxidant defense, mitochondrial functions, Nrf2 
Abbreviations:  
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CAT  Catalase  
DMEM    Dulbecco’s modified eagle medium  
 
FBS   Fetal bovine serum  
Fe/Asc     Iron/Ascorbate  
GAPDH    Glyceraldehyde 3-phosphate dehydrogenase  
G-Px   Glutathione peroxidase  
GSH   Glutathione  
H2O2   Hydrogen peroxide  
IBD    Inflammatory bowel disease  
IκB   Inhibitor of kappa B  
MDA   Malondialdehyde  
MEM   Minimal essential medium  
NF-κB     Nuclear factor-kappa B  
ROS  Reactive oxygen species  
shRNAs     short hairpin RNA  
SOD   Superoxide dismutase  
TBA   Thiobarbituric  
TNF-α    Tumor necrosis factor alpha 
PHB  Prohibitin 
TJ  Tight junction 
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Introduction 
Nrf2 is a transcription factor that regulates the expression of genes containing 
antioxidant-response element (ARE) in their promoters and represents a crucial factor in 
the induction of phase II enzyme in response to stressful conditions [1, 2]. It is 
constitutively controlled by the repressor protein Keap1, which acts as a molecular sensor 
of disturbances in cellular homeostasis [3-5]. During unstressed states, Keap1 suppresses 
cellular Nrf2 in cytoplasm, which drives its proteasomal degradation. Upon induction by 
chemo-preventive agents, Nrf2 is released from Keap-1, translocates to the nucleus, and 
thus controls the expression of genes involved in oxidative defense [6, 7]. Although 
knowledge of Nrf2 function and regulation has progressed significantly in the past years, 
efforts are still needed to uncover the signal-dependent activation of Nrf2 function and 
the precise mechanisms involved. 
Silencing Nrf2 by genetic manipulation renders numerous types of cells and animal 
models much more sensitive to the damaging effects of oxidants and inflammatory agents 
[7, 8]. Conversely, activation of the Keap1-Nrf2 pathway allows survival and adaptation 
under various conditions of stress and has protective effects in many animal models [7, 
9]. Furthermore, protective functions of Nrf2 were reported against a number of 
pathologies that are caused or aggravated by oxidative stress. In many human cancers, 
missense mutations in KEAP1 and Nrf2 genes have been identified [10, 11] and Nrf2 has 
emerged as a novel target for the prevention of colorectal cancer [12]. Moreover, a 
growing body of literature suggests that Nrf2-ARE signaling is involved in attenuating 
inflammation-associated pathogenesis, such as autoimmune diseases, rheumatoid 
arthritis, asthma, emphysema, gastritis, colitis and atherosclerosis [7]. 
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Despite the high levels of Nrf2 in the small intestine and stomach, little attention has been 
devoted to its functions in the gastrointestinal tract. Previous work pointed out the 
protective effect of Nrf2 stimulation against oxidative stress in the gastric mucosa [13]. 
Recently, Nrf2-deficient mice were found to display increased susceptibility to dextran 
sulfate sodium (DSS)-induced colitis [12], while an Nrf2 gene promoter polymorphism 
was associated with ulcerative colitis in  humans [14]. This very limited information truly 
shows little regard for the gastrointestinal mucosa, which is constantly exposed to 
luminal oxidants originating from ingested nutrients [15-17]. Key among these is the 
simultaneous consumption of iron salts and ascorbic acid, which can cause oxidative 
damage to biomolecules [18]. Additionally, the intestinal mucosa is subject to prolonged 
oxidative stress from reactive oxygen species (ROS) generated during aerobic 
metabolism [19]. In addition, the influx of neutrophils and monocytes associated with 
inflammation can generate further ROS via respiratory burst enzymes as well as those 
involved in prostaglandin and leukotriene metabolism [20].  
 
In order to gain more insight into the physiological and biological significance of Nrf2 in 
the intestine, molecular strategies were devised in the Caco-2 cell line, a reliable human 
intestinal model, to thoroughly examine the specific role of Nrf2 in oxidative stress, 
inflammation, epithelial cell cytoprotection and mitochondrion functions.  
 
 6 
Materials and Methods  
Caco-2/15 Cell Culture and Treatment Iron/Ascorbate 
Caco-2/15 cells (ATCC, Rockville, MD) were cultured at 37
o
C in Minimal Essential 
Medium (MEM) (GIBCO-BRL, Grand Island, NY) containing 1% penicillin-
streptomycin and 1% MEM non-essential amino acids (GIBCO-BRL) and supplemented 
with 10% decomplemented fetal bovine serum (FBS) (Flow, McLean, VA). Briefly, 
Caco-2/15 cells (passage 20-30) were maintained in T-75 cm
2
 flasks (Corning Glass 
Works, Corning, NY) as described previously [21, 22]. Culture cells were split (1:6) 
when 90% confluence was reached by the use of 0.05% trypsin-0.5 mM EDTA (GIBCO-
BRL). Cells were cultured for 21 days post confluence, at which the Caco-2/15 cells are 
highly differentiated and appropriate for lipid synthesis and metabolism experiments. To 
determine the implication of oxidative stress per se on Nrf2 mRNA and protein mass, 
Caco-2/15 cells were incubated with different concentrations of iron and ascorbate 
(Fe/Asc) (0.05/2mm, 0.1/2mm, 0.2 mm/2 mm).  
Generation of Stable Short Hairpin RNA Expression in Caco-2/15 cells 
Growing 293FT packaging cell line was transiently cotransfected with 
pLK0.1TRCN000007558 vector (Open Biosystems) harboring short hairpin (sh) RNA 
expression cassettes against human Nrf2 and the Vira Power Packaging Mix (Invitrogen 
Corp., Carlsbad, CA 92008) to generate replication-deficient lentivirus. The produced 
lentivirus stock was five times concentrated with an Amicon Ultra-15 100K centrifugal 
filter device (Millipore) and 35 l were used to infect 250,000 Caco-2/15 cells in six-well 
plates. Forty-eight hours post-infection, cells were transferred to flasks and grown in 
MEM medium containing 1 g/ml puromycin (Sigma-Aldrich, USA) for an additional 7 
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days to establish stable shRNA-expressing Caco-2 cells. Cells were cultivated until 10 
days post-confluence and used only following the validation of the suppression of the 
gene of interest by RT-PCR and Western blot assays. Control cells were obtained by 
infection with Scramble vector lentivirus harboring the same features as the sh construct.  
 
Iron/Ascorbate Exposure and Treatment of Caco-2/15 with Oltipraz  
To determine infected and untreated cell response to oxidative stress, cells were exposed 
to Fe (0.2 mM)/Asc (2 mM) (1:10) system-mediated lipid peroxidation. At the end of a 6-
h culture period, the degree of lipid peroxidation was evaluated by measuring cellular 
malondialdehyde (MDA). Caco-2/15 cells were then incubated with various
 
concentrations of Oltipraz (4-methyl-5-pyrazinyl-3H-1,2-dithiole-3-thione; OPZ) (25, 50 
and 100 M) (Sigma) dissolved in absolute ethanol (ETOH) vehicle and then added to the 
medium, resulting in a final ETOH concentration
 
of 1.6%. Control cells were treated with 
the vehicle only. Cells were pre-treated with OPZ for 20 h before the 6-h incubation with 
Fe/Asc.  
Estimation of Lipid Peroxidation  
The amount of cellular MDA was determined by HPLC as described previously [23]. 
Briefly, proteins were first precipitated with a 10% sodium tungstate (Na2WO4) (Aldrich 
Chemical) solution and the protein-free supernatant was then reacted with an isovolume 
of 0.5% thiobarbituric acid (Sigma) solution at 90°C for 60 min. After cooling to room 
temperature, the chromogene [(TBA)2-MDA] was extracted with 1-butanol and dried 
over a stream of nitrogen at 37°C. The dry extract was then re-suspended in 
KH2PO4/methanol (70:30, pH 7.0) mobile phase before MDA detection by HPLC.  
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Assessment of Intracellular ATP 
Intracellular ATP was measured by luciferase driven bioluminescence using an ATP 
Bioluminescence Assay Kit (Calbiochem, EMD Chemicals, Inc. Gibbstown, NJ) as 
reported previously [21]. Values were normalized with regard to the protein content of 
the respective sample.  
Mitochondrial Preparations 
Mitochondria were isolated using standard differential centrifugation techniques [24]. 
Briefly, Caco-2/15 cells were treated with Fe/Asc (0.2/2 mM) and/or BHT (50 µM) for 6 
h at 37°C. Cells were homogenized with a glass pestle Dounce homogenizer in a buffer 
containing mannitol (210 mM), sucrose (70 mM), Ethylene-bis tetraacetic acid (EGTA) 
(1 mM), fatty acid-FBS albumin (0.5%), and HEPES (5 mM, pH 7.2). The homogenate 
was centrifuged at 1,000  g for 10 min at 4°C. The supernatant was then collected and 
centrifuged at 10,000  g for 10 min to obtain pellets containing mitochondria. The 
pellets were used immediately or stored at −80°C. The protein contents of mitochondrial 
suspension were determined by the Bradford assay (BioRad, Mississauga, ON) with 
bovine serum albumin as a standard. 
Mitochondrial Enzyme Assays 
The activities of respiratory chain complexes were assayed as previously described [24-
26]. Briefly, 20–30 µg of mitochondrial protein were used for each complex every 30 sec 
for 5 min. The activity of complex I (NADH: ubiquinone oxidoreductase) was measured 
by monitoring the reduction of decylubiquinone. Complex II (succinate: ubiquinone 
oxidoreductase) activity was examined by monitoring the reduction of 
dichloroindophenol when coupled to complex II-catalyzed reduction of decylubiquinone. 
Complex III (ubiquinol:ferricytochrome C oxidoreductase) activity was assayed using 
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oxidized cytochrome C. The activity of complex IV (cytochrome C oxidase) was 
determined by oxidation of reduced cytochrome C. Enzyme activities were expressed in 
nmole of substrate used per minute per mg of protein. Enzyme assays for all complexes 
were performed in duplicate in mitochondrial fraction of Caco-2/15 cell line. Complex I, 
II, III and IV chemicals were purchased from Sigma Chemical (St Louis, MO). 
Enzymatic Antioxidant Activity 
The activities of antioxidant enzyme catalase (CAT), superoxide dismutase (SOD) and 
glutathione peroxidase (GPx) were measured in cell homogenates. For enzymatic 
activity, a substrate specific for each enzyme was added to the cell homogenates and rates 
of disappearance of the substrate were measured by spectrophotometry. Caco-2/15 cells 
were harvested in hypotonic lysis buffer [HEPES (10 mM), MgCl2 (1.5 mM), KCl (10 
mM), DTT (0.5 mM), PMSF (0.2 mM)]. Total SOD activity was determined as described 
by McCord et al. [27]. Briefly, O2- was generated by the addition of xanthine and 
xanthine oxidase and the oxidation of the SOD assay cocktail was followed 
spectrophotometrically (550 nm, 5 min) after adding the sample. The assay for CAT 
activity was adapted from the protocol reported by Jiang et al. [28]. Briefly, the oxidation 
of xylenol orange oxidation was measured in the presence of ferrous ions. Absorbance 
(560 nm, 5 min) was monitored after the addition of H2O2 (100 μM). CAT activity was 
calculated using a standard curve. GPx activity was assessed as described previously 
[29]. Cell homogenates were added to a PBS buffer containing GSH (10 mM), 
glutathione reductase (0.1 U) and NADPH (2 mM) with H2O2 (1.5%) to initiate the 
reaction. Absorbance was monitored every 30 sec at 340 nm for 5 min.  
Western Blot for Protein Analysis 
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The Bradford assay (BioRad) was used to estimate protein concentration. Cells were 
homogenized and proteins (30 μg) were denatured at 95°C for 5 min in sample buffer 
containing sodium dodecyl sulphate (SDS) andmercaptoethanol separated on a 
10% SDS-PAGE gel and electroblotted onto nitrocellulose membranes (Amersham). 
Membranes were blocked in Tris-buffered saline [20 mM Tris-HCl (pH 7.5) plus 137 
mM NaCl] dry milk for 60 min at room temperature as described previously [22]. The 
blots were then incubated overnight at 4°C in blocking solution containing the 
antibodies for Nrf2 (Abcam, USA), Inhibitor of kappa B (IB) (Sigma-Alrich), 
Nuclear factor-kappa B (NF-B) (Sigma-Aldrich), peroxisome proliferation activator 
receptor-γ coactivator-1alpha (PGC-1Abcam), Prohibitin (Thermo Scientific, 
Canada), Tumor Necrosis Factor-alpha (TNF-) (Sigma), B cells lymphoma-2  (Bcl2) 
(Abcam), Occludin (Abcam) and β-actin (Sigma-Aldrich). Blots were developed and 
the protein mass was quantified using an HP Scan jet scanner equipped with a 
transparency adapter and the UN-SCAN-IT gel 6.1 software. 
Semi-Quantitative RT-PCR  
Experiments for mRNA quantification as well as for the housekeeping gene GAPDH 
were performed in Caco-2/15 cells using the UNO II thermocycler (Biometra) as reported 
previously [30]. Briefly, total RNA was isolated and reverse transcripted into cDNA. 
PCR amplification was then performed in 50 μl volume using 5 μl PCR Buffer (10 X), 
1.5 μl MgCl2 Solution, 2 μl dNTPs (2.5 mM), 0.2 μM of each corresponding primer and 
2.5 U of TAQTM Platinum Polymerase (Qiagen). The sequences for mouse Nrf2 primers 
were 5'-TCTCCTCGCTGGAAAAAGAA-3' and 3'-AATGTGCTGGCTGTGCTTTA-5'. 
Between 30 and 40 cycles of amplification were used at 95ºC for 30 s, 58ºC for 30 s and 
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72ºC
 
for 30 s. Amplicons were visualized on standard ethidium bromide-stained agarose 
gels. Quantification was determined with the software UN-SCAN-IT gel 6.1.  
Statistical Analyses 
Statistical analyses of data were performed with Prism 4.03 software (GraphPad 
Software, CA). All values were expressed as the mean ± SEM. The data were evaluated 
by ANOVA and the differences between the means were assessed using the Bonferroni’s 
multiple comparison test. A P-value of less than 0.05 was considered to be significant. 
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Results 
Nrf2 Expression in Response to Oxidative Stress 
In order to test the status of Nrf2 expression and its response to oxidative stress, Caco-
2/15 cells were incubated with the Fe/Asc oxygen radical-generating system. As 
illustrated in Fig. 1A, the incubation of differentiated Caco-2/15 cells with increasing 
amounts of Fe/Asc promoted steady lipid peroxidation, which was assessed by measuring 
MDA. 
The same concentrations of Fe/Asc were employed to determine the modulation of Nrf2. 
Treatment of Caco-2/15 cells with the low dose of Fe (0.05 mM), combined with Asc 
(2mM), induced a marked rise in Nrf2 protein expression, whereas high levels of Fe (0.1 
and 0.2 mM) lowered Nrf2 protein mass (Fig. 1C). It is worth noting that no significant 
changes were observed in Nrf2 mRNA with the variable Fe doses combined with 2 mM 
Asc (Fig. 1B).   
Nrf2 Protein Level Modulation by OPZ 
OPZ is an Nrf2 activator capable of preventing oxidative stress, which highlights the 
importance of the Nrf2 antioxidant system. To examine the ability of this chemical agent 
to regulate Nrf2 in the intestinal system, Caco-2/15 cells were treated with OPZ in the 
presence and absence of Fe/Asc (0.2/2 mM). The presence of OPZ increased Nrf2 protein 
expression and prevented Fe/Asc-mediated Nrf2 protein lessening (Fig. 2B). Once again, 
Nrf2 transcripts were unaltered with OPZ and/or Fe/Asc treatments (Fig. 2A).  
Lentiviral Knockdown of Nrf2 in Caco-2/15 Cells 
To define the role of Nrf2 in various intestinal processes, including oxidative stress, 
inflammation and mitochondrial functions, we used stable Caco-2/15 cells together with 
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shRNA constructs targeting Nrf2-encoding mRNA. Nrf2 expression was measured in 
several clones and compared with the control and scramble-containing vector (SV) cells. 
As invariable results were recorded between untreated and SV cells (data not shown), 
only the latter were employed as control cells for the subsequent studies. Nrf2 was 
inactivated in a concentration-dependent manner within 10 μl-35 μl as illustrated by 
decreased gene (Fig. 3A) and protein (Fig. 3B) compared with untreated cells. In order to 
investigate the effect of OPZ on Nrf2 residual expression, we used the most efficient 
cellular clone. Under these conditions, OPZ was able to significantly increase Nrf2 in 
control SV, but without equivalent magnitude in Nrf2 shRNA-infected cells (Fig. 3C).  
Nrf2 Knockdown and Endogenous Antioxidant Enzymes  
The enzymatic antioxidant pathway protects the cells against free radicals and ROS 
excess to maintain an oxidative balance. Figure 4 shows that the activity of CAT, GPx 
and cytoplasmic SOD was significantly reduced in Nrf2 shRNA-infected cells in 
comparison with control SV cells. Following treatment with OPZ, the activity of the three 
enzymes was found substantially enhanced in SV, but only moderately elevated in Nrf2 
shRNA-infected cells (Fig. 4).  
Nrf2 Knockdown and Inflammatory Markers  
The NF-κB signaling pathway plays a crucial role in the initiation, amplification and 
resolution of inflammation by controlling the expression of multiple inflammatory 
mediators. In the cytosol, NF-κB is linked to its inhibitory molecule IκB. When IκB is 
degraded in response to various stimuli, NF-κB translocates to the nucleus where it 
activates the transcription of pro-inflammatory target genes. Administration of Fe/Asc to 
Caco-2/15 enhanced NF-κB (Fig. 5B) and decreased IκB (Fig. 5C). This effect was 
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Fe/Asc concentration-dependent. Measurement of TNF-α in Caco-2/15 treated with 
increasing concentrations of Fe/Asc showed a similar increase pattern (Fig. 5A).  In Nrf2 
shRNA-infected cells, NF-κB protein expression is increased (Fig. 6B) and IκB protein 
expression is reduced (Fig. 6C) compared with SV, suggesting that the inhibitory protein 
is degraded in the proteasome, leaving NF-κB free to enter the nucleus and activate the 
transcription of its target genes. Accordingly, the protein expression of TNF-α, a target of 
NF-κB, was increased in Nrf2 shRNA-infected cells (Fig. 6A). Administration of OPZ 
prevented the changes of NF-κB, IκB and TNF-α in Nrf2 shRNA-infected cells. 
Nrf2 Involvement in Oxidative Phosphorylation Activity 
We evaluated the activity of mitochondrial oxidative phosphorylation (OXPHOS) in 
Caco-2/15 cells treated with Nrf2 shRNA and/or OPZ. Our findings documented a 
significant reduction in the specific activities of complex I, II, III and IV in Nrf2 shRNA-
infected Caco-2/15 cells (Fig. 7) compared with SV. Moreover, OPZ treatment enhanced 
the activities of complex I, II, III and IV in control Caco-2/15 cells, but only produced a 
moderate upregulation of these mitochondrial enzymes in the Nrf2 shRNA-infected 
Caco-2 cells. 
Relationship between Nrf2 Silencing and Mitochondrial ATP Levels  
The main function of the mitochondrion is the production of energy in the form of ATP 
via OXPHOS and oxygen consumption. We therefore assessed the amount of ATP levels 
in Nrf2 shRNA-infected Caco-2 cells in the presence and absence of OPZ. As noted in 
Figure 8, there was a significant reduction in ATP levels in Nrf2 shRNA cells compared 
with SV-treated cells. Furthermore, pre-incubation of Caco-2/15 with OPZ resulted in a 
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significant rise in ATP levels compared with cells without OPZ. These results indicate 
the regulatory role of Nrf2 in mitochondrial ATP production.  
Nrf2 Regulation of Prohibitin  
Prohibitin (PHB), a chaperon protein located on the inner mitochondrial membrane, 
exhibits antioxidant and anti-inflammatory effects [31,32]. Our results show a dramatic 
reduction in PHB levels after Fe/Asc-induced oxidative stress in Caco-2 cells (Fig. 9A).  
A similar effect was recorded with Nrf2 inactivation (Fig. 9B). OPZ was able to 
substantially increase PHB protein expression in SV, but less markedly in Nrf2 shRNA 
Caco-2/15 cells.  
Nrf2 and Intestinal Permeability 
Intestinal permeability defects may contribute to intestinal loss of cell junctional sealing 
by defective tight junctions and may be involved in the pathogenesis of inflammatory 
bowel diseases [33,34]. Figure 10 shows a significant reduction in occludin protein 
levels, one of major TJ transmembrane barrier proteins, in Caco-2/15 cells treated with 
high concentration of Fe/Asc (Fig. 10A) or Nrf2 shRNA (Fig. 10B). OPZ showed little 
effect on Nrf2 decline in Nrf2 shRNA Caco-2/15 cells. 
Nrf2 Anti-Apoptotic Effects via Upregulation of Bcl-2 
In the process of programmed cell death, mediators of apoptosis are released from 
mitochondria through disruptions in the outer mitochondrial membrane and then 
participate in caspase activation and DNA degradation. In our study, we focused on one 
specific mediator of the outer mitochondrial membrane, Bcl-2. High concentrations of 
Fe/Asc lowered Bcl-2 protein expression in control cells (Fig. 11A). Simple ablation of 
Nrf2 led to similar negative results (Fig. 11B). Treatment with OPZ markedly augmented 
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Bcl-2 protein expression but was unable to display an equivalent effect in Nrf2 shRNA 
Caco-2/15. 
Nrf2 Contribution to Mitochondrial Biogenesis via Regulation of PGC-1 
PGC-1α is a key player in ROS-induced mitochondrial biogenesis. Nrf2 serves as a 
cellular sensor for oxidative stress and PGC-1α. We determined the effect of oxidative 
stress and Nrf2 knock-down on mitochondrial biogenesis by measuring PGC-
1expression in Caco-2/15 cells treated with various doses of Fe/Asc or infected with 
Nrf2 shRNA. We observed a significant reduction in PGC-1protein expression 
inCaco-2/15 cells treated with either with Fe/Asc (Fig. 12A) or in Nrf2 shRNA 
transfection (Fig. 12B) compared with untreated cells. Along with these results, OPZ was 
capable of inducing PGC-1protein expression only in SV cells.   
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Discussion 
Multiple studies have shown the importance of oxidative stress and inflammation in the 
pathogenesis of intestinal diseases following the attenuation of oxidative stress by 
antioxidant treatment in cell culture and colitis prevention in experimental animal models 
[35-37]. Despite these promising results, antioxidants have not proven to be effective in 
human diseases, though the expression of most antioxidant enzymes is tightly controlled 
upon Nrf2 activation [3,5]. In the present study, we identify several new pathways 
positively regulated by Nrf2 and we provide evidence for its direct or indirect implication 
in counteracting oxidative stress, inflammation and mitochondrial dysfunction in 
intestinal epithelial cells.   
In order to examine a variety of intestinal functions, we used the Caco-2/15 cell line that 
exhibits many of the features of small intestinal epithelial cells and reproduces several of 
the normal physiological responses to various regulatory agents [21,22]. In addition, we 
employed the powerful Fe/Asc
 
oxygen radical-generating system to investigate the 
modulation of Caco-2/15 cell mitochondrial function by oxidative stress [38,39]. 
In this study, we treat Caco-2/15 cells with increasing concentrations of Fe/Asc 
(0.05/2mM, 0.1/2mM, 0.2/2mM), which displayed different impacts on lipid peroxidation 
and on Nrf2 modulation. We found an increase in MDA levels, a marker of lipid 
peroxidation, in a dose-dependent manner. Interestingly, at low concentrations, Fe/Asc 
augmented Nrf2 protein levels compared with control cells. This typical response to mild 
oxidative stress is physiologically relevant, as it could lead to Nrf2 dissociation from its 
inhibitor Keap1 and its translocation to the nucleus, inducing a protective response. In 
contrast, increasing the concentration of Fe/Asc (0.2/2mM) led to reduced Nrf2 protein 
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levels. This may refer to severe oxidative stress observed in pathological states and could 
possibly be associated with increased Nrf2 degradation, leading to lower translocation to 
the nucleus. 
OPZ is
 
a chemopreventive compound that induces antioxidant
 
protection either
 
by a 
mechanism
 
involving a cellular response to increased production of ROS [40] or the 
perturbation of the Keap1-Nrf2 complex secondary to Keap1 cysteine residue 
modification ultimately leading to Nrf2 dislocation [41]. In our study, optimal 
concentrations of OPZ (50 M) induced a significant Nrf2 increase and effectively 
attenuated cellular oxidative stress. Our findings, showing that the Nrf2 knock-down 
abrogates the protective effects of OPZ against Fe/Asc provide concrete evidence about 
the direct contribution of Nrf2 to antioxidant actions.  
 
The increase in SOD, CAT and GPx activities following OPZ treatment is consistent with 
a previous study by Ramos-Gomez and collaborators, which demonstrated that loss of 
expression of Nrf2 completely abrogates the protective effect of OPZ. This would be 
a more direct observation of the relationship between these 2 pathways [42]. Further 
support for our data is evidenced by a previous report noting that sulforaphane, an OPZ 
activator, stimulated Nrf2 gene-dependent antioxidant enzyme activity and protected 
against oxidative stress in gastric mucosa [13]. Finally, Nelson et al. observed that OPZ is 
effective in protecting retinal pigment epithelial cells from oxidative damage via Nrf2 
production [41]. 
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Our results highlighted the anti-inflammatory properties of Nrf2. We observed a 
reduction in NF-, TNF- and an upregulation of levels upon induction of Nrf2 
with OPZ. Conversely, inhibition of Nrf2 shRNA infection enhanced NF- and TNF-, 
but down-regulated I. Similarly, increased concentrations of Fe/Asc stimulated NF- 
and TNF- but showed opposite effects on. This is consistent with previous studies 
by Khor et al. who observed raised levels of pro-inflammatory mediators, such as IL-6 
and TNF-α, in the colonic tissues of Nrf2-deficient mice [12]. It has also been noted that 
NF-κ activation could be attenuated by Nrf2 activators, such as phenethyl 
isothiocyanate and curcumin [43]. Supportive data were noted in cystic fibrosis epithelia 
where dysfunction of Nrf2 leads to excess intracellular H2O2 and pro-inflammatory 
cytokine production [44]. Nevertheless additional studies are needed to show that Nrf2 
can directly inhibit NF-k.   
 
PHB is an ubiquitously expressed and highly conserved protein that has multiple 
functions, including antioxidant defense, anti-inflammatory responses, cellular 
proliferation, apoptosis regulation and mitochondrial protein folding [45]. PHB is 
localized on the cell membrane, mitochondrial membrane or nucleus, depending on cell 
type and physiological conditions [31,46]. PHB has been shown to link two subunits of 
complex IV in yeast [47] and with subunits of complex I in mammals [48]. A recent 
study suggests that PHB is a regulator of Nrf2 expression during oxidative states and 
prevents inflammation-associated oxidative stress through sustained activation of Nrf2 
[46]. It has been demonstrated that Caco-2 cells overexpressing PHB are protected from 
oxidative stress, whereas PHB is decreased in experimental colitis [31]. In the current 
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investigation, we demonstrated that Nrf2 activation by OPZ enhances mitochondrial PHB 
expression, while Nrf2 knockdown led to a reduction in mitochondrial PHB. A decrease 
in PHB was also observed with high Fe/Asc concentrations in the experimental system. 
Therefore, we suggest that Nrf2 is a master regulator of PHB expression. One possible 
explanation for these findings is that PHB and Nrf2 regulations are dependent and have 
synergistic actions within the cells, but such proposal has to be validated. Muraguchi et 
al. have observed that PHB overexpression inhibits the hypoxia-induced decrease in 
mitochondrial membrane potential levels and Bcl-2 [49]. Thus, it is reasonable to propose 
that there is a functional triangle linking Nrf2, PHB and Bcl-2, which share anti-apoptotic 
and antioxidant functions. 
 
Surprisingly, few studies have focused on the relationship between Nrf2 and apoptosis 
[4]. Our results provide evidence for the first time that Nrf2 upregulation by OPZ 
contributes to elevation of Bcl-2 anti-apoptotic protein in Caco-2/15 cells, while Nrf2 
knockdown or increasing Fe/Asc concentrations downregulates Bcl-2. Various 
hypotheses can be proposed to explain Nrf2 antiapoptotic activities. The upregulation of 
glutathione, SOD and CAT mediated by Nrf2 is likely to be one of the mechanisms by 
which these antioxidant enzymes prevent inflammation and cell death. Accordingly, 
recent data have reported that Nrf2 overexpression protects cells from Fas-mediated 
apoptosis, suggesting an important role for Nrf2 in antiapoptotic pathways [50]. On the 
other hand, it may be suggested that Nrf2 induces the expression of prosurvival Bcl-2 
family members directly or indirectly via upregulation of PHB, since previous work 
demonstrated repression of proapoptotic BAX/BAK expression via PHB upregulation 
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[51]. In line with these observations, treatment with resveratrol, an Nrf2 activator, 
prevented vascular apoptotic cell death in high fat diet Nrf2+/+ mice, without the same 
success in high fat diet Nrf2-/- mice[52]. In summary, we suggest that Nrf2 acts as an 
important antiapoptotic mediator and that the underlying mechanism involves activation 
of Bcl-2.   
 
The disruption of intestinal epithelial barrier function has traditionally been attributed to 
proinflammatory cytokines. As noted previously, TNF-α generation reduces intestinal 
epithelial TJ permeability and contributes to intestinal barrier damage [53]. We have 
explored the possibility of Nrf2 involvement in the regulatory function of intestinal TJs 
such as occludin. For the first time, we have established an association between Nrf2 and 
occludin, since Nrf2 induction with OPZ upregulated occludin levels. We have also 
demonstrated that Caco-2/15 cells treated with Nrf2 shRNA or with increasing 
concentrations of Fe/Asc display lower occludin levels. Our results are in line with 
previous data suggesting a reduction in the proteasome-mediated degradation of occludin 
in the intestinal mucosa of subjects with inflammatory bowel syndrome [54]. Assembly 
of occludin in the TJ network was also observed with confocal microscopy in Caco-2 
cells in response to Nrf2 induction by kaempferol, a natural flavonoid [55]. Overall, these 
data suggest a central role for Nrf2 in small intestine integrity preservation. 
 
Mitochondrial biogenesis is dependent on external stimuli and an orchestrated crosstalk 
between the nuclear and mitochondrial genomes and PGC-1α may represent a crucial 
factor linking external stimuli to mitochondrial biogenesis [56]. For example, PGC-1 
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could interact with Nrf2 to transactivate a number of genes involved in mitochondrial 
functions such as OXPHOS as well as in protein import and heme biosynthesis. PGC-1 
also mediates mitochondrial DNA transcription and replication through two nuclear-
encoded genes: mitochondrial transcription factor A and B [57]. Our results provide 
strong evidence that enhancing Nrf2 activity by OPZ in Caco-2/15 cells contributes to 
mitochondrial biogenesis and function via upregulation of PGC-1, an increase in 
mitochondrial enzymatic activity and ultimately a rise in ATP production. Surprisingly, 
we found a dramatic decrease in PGC-1in Caco-2/15 infected with Nrf2 shRNA or 
incubated with high concentrations of Fe/Asc in comparison with SV-treated or control 
cells. Our results are in agreement with a previous study showing a significant reduction 
in PGC-1in retinal epithelial cells treated with oxidative stress [58]. Since mice with a 
targeted disruption of PGC-1remained viable and showed no change in mitochondrial 
abundance or morphology in the liver, we propose that Nrf2 could act in an independent 
fashion to enhance mitochondrial function and biogenesis [59]. Thus, the absence of a 
dramatic mitochondrial biogenesis defect in PGC-1 null mice may result from 
compensatory mechanisms. It remains an open question as to whether Nrf2 can support 
basal levels of mitochondrial biogenesis independent of PGC-1 and whether Nrf2 
overexpression leading to increased PGC-1 levels represents a physiologically 
meaningful pathway of retrograde regulation in human cells. Accordingly, a recent study 
showed that Nrf2 could bind to cytochrome oxidase subunit IV promoters prior the 
activation of PGC-1.  
We previously demonstrated that an accumulation of lipid peroxidation products in the 
mitochondria due to high concentrations of Fe/Asc leads to a decrease in ATP production 
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and compromises the maintenance of cellular homeostasis [21]. Similarly, in this study, 
incubation of Caco-2/15 cells with Nrf2 shRNA induced a marked decrease in ATP 
production. In contrast, ATP production was significantly increased in Caco-2/15 cells 
following treatment with OPZ. Therefore, our data are consistent with previous 
investigations documenting a decline in ATP in HT-29 intestinal cells with Nrf2 deletion 
[61]. In the present investigation, the decrease in ATP synthesis is probably related to the 
low mitochondrial metabolic activity resulting from Nrf2 knockdown-mediated lipid 
peroxidation. We reasonably suggest that mitochondrial dysfunction in cells treated with 
Nrf2 shRNA is due to the low efficiency of mitochondrial respiratory chain enzymes, 
followed by a decline in ATP production.  
 
Taken together, our data indicate that an increase in Nrf2 in intestinal epithelial cells 
plays a pivotal role in positively modulating cellular defense and maintaining cellular 
integrity against toxic insults. For the first time, our study reveals the capacity of Nrf2 to 
regulate many intestinal genes and enzymes (occludin, PHB, PGC-1, Bcl-2) related to 
cell permeability and mitochondrial functions. It is quite possible that some of these 
expressed proteins could be secondary to or indirectly affected by Nrf2-controlled genes. 
Therefore, further studies are required to test this assumption. 
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Figures and Legends 
 
Fig. 1: Nrf2 Expression and MDA Level in Caco-2/15 Cells Treated with Increasing 
Amount of Fe/Asc  
Caco-2/15 cells treated with increasing amount of Fe/Asc. Lipid peroxidation was 
evaluated by measuring MDA with HPLC (Fig. 1A). RT-PCR and Western blot were 
performed to assess Nrf2 mRNA (Fig. 1B) and protein levels (Fig. 1C), respectively. 
Cells that were not treated with Fe/Asc served as basic controls. Results represent the 
means ± SEM of n = 3 independent experiments. *P < 0.05 vs. control cells. 
 
Fig. 2 Nrf2 Modulation in Caco-2/15 Cells Treated with OPZ.  
RT-PCR and Western blot were used to evaluate the modulation of Nrf2 gene expression 
(Fig. 2A) and protein levels (Fig. 2B), respectively, in Caco-2/15 following treatment 
with 50 M of OPZ. Results represent the means ± SEM of n = 3 independent 
experiments. *P < 0.05 vs. control cells. 
 
Fig. 3 Nrf2 Expression in Caco-2/15 Cells Infected with Short Hairpin RNAs 
(shRNAs)  
Following lentivirus infection, Caco-2/15 cells were tested for Nrf2 gene (Fig. 3A) and 
protein (Fig. 3B) expression. RT-PCR was performed for gene expression and Western 
blot for protein mass. Caco-2/15 cells were infected with various concentrations of Nrf2 
shRNA. Cells that were not treated with lentivirus served as basic controls. Western blot 
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was used to evaluate the level of Nrf2 protein (Fig. 3C) following treatment with 50 M 
of OPZ in Caco-2/15 infected with shRNA. Results represent the means ± SEM of n = 3 
independent experiments. *P < 0.05 vs. control cells or SV cells. 
 
Fig. 4 Endogenous Antioxidant Activities in Caco-2/15 Cells Infected with Nrf2 
shRNA 
Enzyme activities of CAT, GPx and SOD (respectively, Fig. 4.A, Fig. 4B and Fig. 4C) 
were measured by spectrophotometric assays in Caco-2/15 cells in response to Nrf2 
knockdown with or without OPZ. Enzyme activities are expressed as nmol/min/mg 
protein. Results represent the means ± SEM of n = 3 independent experiments. *P < 0.05 
vs. SV cells. 
 
Fig. 5: Inflammatory Mediators in response to Fe/ASC Treatment in Caco-2/15 
Cells 
Western blots were performed to determine TNF, NF- and IB (respectively, Fig. 
5A, Fig. 5B and Fig. 5C) protein levels in Caco-2/15 cells treated with increasing 
concentrations of Fe/Asc. Results represent the means ± SEM of n = 3 independent 
experiments. *P < 0.05 vs. control cells. 
 
Fig. 6: Inflammatory Mediators in Response to Nrf2 Knockdown in Caco-2/15 Cells 
Western blots were performed to determine TNF, NF- and IB (respectively Fig. 6A, 
Fig. 6B and Fig. 6C) protein levels in Caco-2/15 cells infected with Nrf2 shRNA. Results 
represent the means ± SEM of n = 3 independent experiments. *P < 0.05 vs. SV cells. 
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Fig. 7 Regulation of Mitochondrial Respiratory Chain Complexes Activities in Nrf2 
shRNA Caco-2/15 Cells  
Enzyme activities of mitochondrial respiratory chain complexes I, II, III, IV (respectively 
Fig. 7A, Fig. 7B, Fig. 7C and Fig. 7D) were measured by spectrophotometric assays in 
Caco-2/15 cells treated with Nrf2 shRNA and with or without OPZ. Enzyme activities are 
expressed as nmol/min mg protein. Results represent the means ± SEM of n = 3 
independent experiments. *P < 0.05 vs. control cells or SV cells. 
 
Fig. 8 ATP Levels in Nrf2 shRNA Caco-2/15 Cells  
Intracellular ATP was measured by bioluminescence assay. Caco-2/15 cells were treated 
with Nrf2 shRNA with or without OPZ. Results are expressed as ng of ATP per mg of 
cellular protein and represent the means ± SEM of n = 3 independent experiments. *P < 
0.05 vs. control cells. 
 
Fig. 9 Modification of PHB Expression in Caco-2/15 Cells Treated with Fe/Asc or 
Nrf2 shRNA  
Western blots were performed to detect the protein level of PHB in Caco-2/15 cells 
treated with increasing concentration of Fe/Asc (Fig. 9A) or with Nrf2 shRNA (Fig. 9B). 
Results represent the means ± SEM of n = 3 independent experiments. *P < 0.05 vs. 
control cells or SV cells. 
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Fig. 10 Occludin Regulation in Caco-2/15 Cells Treated with Fe/Asc or Nrf2 shRNA  
Occludin protein levels were determined by Western blot in Caco-2/15 cells treated with 
increasing concentrations of Fe/Asc (Fig. 10A) or with Nrf2 shRNA (Fig. 10B). Results 
represent the means ± SEM of n = 3 independent experiments. *P < 0.05 vs. control cells 
or SV cells. 
 
Fig. 11 Disruption of Bcl2 in Caco-2/15 Cells Treated with Fe/Asc or Nrf2 shRNA 
Bcl-2 protein levels were determined by Western blot in Caco-2/15 cells treated with 
increasing concentrations of Fe/Asc (Fig. 11A) or with Nrf2 shRNA (Fig. 11B). Results 
represent the means ± SEM of n = 3 independent experiments. *P < 0.05 vs. control cells 
or SV cells. 
 
Fig. 12 Decrease of PGC-1 in Caco-2/15 Cells Treated with Fe/Asc or Nrf2 shRNA  
PGC-1 protein levels were determined by Western blot in Caco-2/15 cells treated with 
increasing concentrations of Fe/Asc (Fig. 12A) or with Nrf2 shRNA (Fig. 12B). Results 
represent the means ± SEM of n = 3 independent experiments. *P < 0.05 vs. control cells 
or SV cells. 
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6 DISCUSSION 
The Caco-2/15 cell line has been used to examine a variety of intestinal functions [136, 
165, 166]. Because Caco-2/15 cells exhibit many of the features of intestinal epithelial cells 
and reproduce several of the normal physiological responses to various regulatory agents, 
we have employed this intestinal model to determine whether the FE/ASC oxygen radical-
generating system modulates mitochondrial functions.  
 
Iron is the most abundant transition metal in mammalian cells and is essential for the 
physiological functions of multiple proteins. However, excess iron can be detrimental 
because it can initiate oxygen radical formation and promote ROS [21, 33].  
 
It has been found that iron increases disease activity in colitis and this is associated with 
oxidative stress, neutrophilic infiltration and increased pro inflammatory cytokines [27]. 
Thus, iron may cause oxidative damage to biological macromolecules and alter the 
intracellular redox environment, thereby affecting redox-sensitive cell signaling pathways 
and transcription factors [18, 19]. Although the mechanisms underlying the cytotoxicity of 
iron in different tissues are not fully investigated, data have indicated the contribution of 
iron-mediated peroxidation in numerous pathological states, including atherosclerosis, 
cancer, ischemia-reperfusion injury, IBD and conditions of iron overload [22, 25, 33, 167].  
 
Several studies have shown the ability of iron to initiate strong lipid peroxidation, whereas 
ascorbic acid can amplify the oxidative potential of iron by promoting metal ion-induced 
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lipid peroxidation [21, 168]. Our data indicate that the FE/ASC system functioned as a 
producer of lipid peroxidation and, at the same time, altered the function of mitochondria. 
 
In this study, the incubation of Caco-2/15 cells with FE/ASC induced a marked lowering in 
ATP production level that is probably related to the low mitochondrial metabolic activity 
resulting from the FE/ASC-mediated lipid peroxidation. In fact, electron movement through 
complexes I, II, III and IV enables the movement of hydrogen ions across the inner 
membrane into the inter-membrane space, thus creating an electrochemical gradient, which 
is harnessed into ATP production by ATP synthase in complex V. We suggest that 
mitochondrial damage from ROS may lead to a degradation in the mitochondrial 
respiratory chain enzymes (complexes I, II, III, IV), and hence a decline in the ATP 
production. Finally, blockage of mitochondrial electron transport chain enzymes and/or 
ATP-synthase may account for the ATP inhibition triggered by the administration of 
FE/ASC to Caco-2/15 cells.  
The increase in ROS production might interrupt the electron transport chain and affect ATP 
production. The possible mechanism may be attributable to ROS-induced cardiolipin 
damage. Under normal physiological conditions, cardiolipin anchors cytochrome C protein 
to the inner mitochondrial membrane where it participates in the electron transport between 
complexes III and IV of the respiratory chain. During oxidative stress, cardiolipin 
peroxidation could be crucial for enabling cytochrome C dissociation from the 
mitochondrial inner membrane along with anomalies of electron transport (between 
complexes III and IV of the respiratory chain) and ATP production. 
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Mitochondria also play a part in modulating the amplitude of Ca2+ signals through rapidly 
accumulating and releasing Ca2+ [67, 83]. However, excessive mitochondrial Ca2+ overload 
can trigger ROS overproduction, mitochondrial membrane depolarization and ATP 
inhibition [72, 83, 85]. Additionally, these defective processes may eventually lead to 
apoptosis [72, 87]. Therefore, molecules capable of minimizing mitochondrial Ca2+ 
overload would decrease mitochondrial ROS accumulation and improve mitochondrial 
energy production, which may impact on mitochondrial-oxidative mediated diseases.  
 
The core human mitochondrial transcription machinery comprises a single subunit 
bacteriophage-related RNA polymerase (POLRMT), mt TFA and two transcriptional co-
activator proteins, h-mtTFB1 and h-mtTFB2 [103]. Both factors appear to interact directly 
with POLRMT forming a heterodimer that, in addition to mt TFA, is required for the 
accurate initiation of both H1 and L promoters. We demonstrated that mt TFA, mt TFB1, 
mtTFB2 transcriptional level and protein mass were augmented in the presence of FE/ASC. 
This increase in the experiments represents a compensatory mechanism in response to the 
oxidative stress-related condition. 
In our experiments, we found that FE/ASC increase in 8-OHdG. It has been observed 
previously by other researchers that 8-OHdG represents one of the most frequently 
generated oxidative base lesions within DNA, and one of the most common threats to 
mitochondrial genome stability [73, 77, 86, 143]. Furthermore, nuclei were not affected by 
FE/ASC-mediated OS, which confirms that mt DNA is more vulnerable than nuclear DNA 
to oxidative damage given that it is situated  close to the site of ROS generation and,  
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concomitantly, mitochondria lack protective histones and have far fewer mechanisms that 
prevent reduced base excision repair activity compared to nucleus DNA [143]. 
 
OGG1 is the DNA repair enzyme that recognizes and excises 8-oxodG [79, 80]. The 
present study shows that the incubation of Caco-2/15 cells with FE/ASC has resulted in a 
marked decrease in OGG1 transcript level and protein mass. Deficiency in DNA repair 
enzyme OGG1 has likely important functional consequences that compromise the ability of 
cells to repair DNA. A previous study suggests that increased 8-OHdG levels in colorectal 
carcinoma are attributed to increased formation and are maintained elevated by diminished 
8-OHdG repair activity at appropriate high levels [79]. Finally, these results indicate that 
mt DNA damage following oxidative stress can lead to a vicious cycle of ROS propagation 
and mt DNA oxidation.  
 
The cascade initiated by oxidative mt DNA damage leads to the deficiency of key electron 
transport enzymes, and subsequent ROS generation may ultimately dramatically release 
death signals, such as cytochrome C and AIF.  Mt DNA damage represents a key target for 
intervention and a biomarker in the course of many human diseases. We believe that mt 
DNA damage is linked to the numerous abnormal processes noted in our research, 
including ATP generation, Ca2+ homeostasis and release of signals of cell death.  
 
In summary, the FE/ASC system in Caco-2/15 appeared to be very effective in promoting 
lipid peroxidation and, at the same time, altered the mitochondrial function. This 
mitochondrial dysfunction is probably related to oxidative stress because the addition of 
antioxidants (BHT) prevented the occurrence of lipid peroxidation and improved 
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mitochondrial functions in terms of ATP production, Ca2+ homeostasis and apoptotic 
protein expression.  
 
Our results show for the first time that FE/ASC can induce lipid peroxidation accompanied 
by a defect in ATP production, mitochondrial transport chain complex inhibition, 
mitochondrial Ca2+ overload, cell apoptosis, mitochondrial DNA damage and 
mitochondrial transcription factors alterations in intestinal epithelial cells. All hallmark 
events of mitochondrial dysfunction are clearly found in our study.  
 
Our findings support the clinical observation that iron supplementation enhances disease 
activity in patients with chronic intestinal inflammation. The iron dose used in the current 
study is comparable to normal iron concentration in the gut [5].  
 
Overall, our data suggest that oxidative-mitochondrial dysfunctions are not mediated by a 
single gene or mechanism, but it instead may be a consequence of multiple factors 
organized within a complex functional network. The pattern of our results may prove to be 
useful in elucidating the molecular mechanisms implicated in IBD. 
 
Multiple studies have shown that the significance of oxidative stress and inflammation in 
the pathogenesis of intestinal diseases. In fact, antioxidant treatments attenuate the 
oxidative stress in cell culture and improve colitis in experimental models [134, 169, 170]. 
Despite these studies, antioxidants have yielded disappointing results and have not proven 
to be effective in human diseases. High amounts of antioxidants are needed to achieve 
protective effects in the intestine, as most exogenous antioxidants do not cross the blood 
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brain barrier owing to their hydrophilic nature. Furthermore, administration of antioxidants 
is limited owing to their toxicity at high dose, resulting in small therapeutic window of 
these molecules.  
 
Thus, it is important to emphasize the need for alternative strategies to therapeutically 
counteract the oxidative stress-mediated diseases. In recent years, scientific interest has 
focused increasingly on other mediators that have shown important regulatory roles in 
various body functions. A promising molecule to inhibit ROS-mediated damage is the 
activation of endogenous antioxidant enzymes present in the intestine via activation of 
nuclear transcription factors such as Nrf-2. 
 
Nrf2 is an important redox-sensitive nuclear transcription factor which protects against 
oxidative stress by inducing the transcription of antioxidant and detoxifying genes through 
binding with ARE [151, 171]. It has the potential to be a target to intervene in a variety of 
diseases, such as neurodegenerative, cardiovascular, pulmonary and chronic inflammatory 
diseases, where oxidative stress  occurs and Nrf2 is degraded [146, 160, 164, 172]. Several 
approaches can be utilized to activate Nrf2 or reduce its degradation through modulating its 
post-translational modifications (e.g. phosphorylation and acetylation) or Keap1 stability 
[151, 153]. Therefore, the development of a specific Nrf2 activator to switch on its 
responsive genes would bring novel avenues for the treatment of oxidative stress related 
disease.  
 
To evaluate the anti-oxidants function of Nrf2 in oxidative stress, inflammation, apoptosis, 
intestinal permeability and mitochondrial functions in Caco-2/15 cells, we employed the 
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FE/ASC oxygen radical-generating system to determine how Nrf2 modulates mitochondrial 
dysfunction related to oxidative stress in Caco-2/15 cells. 
 
Our results revealed that the increase in Nrf2 activity plays a pivotal role in modulating the 
classical ARE-driven gene and in regulating many genes and enzymes, including PHB, 
PGC-1α, occludin, TNFα and Bcl-2 that have not been verified before as being under 
direct control of Nrf2.  The up-regulation of these enzymes and proteins may represent an 
adaptive response occuring in face of exposure to oxidative insults. This adaptive response 
is regulated by an interaction between Keap1 and Nrf2 in which the exposure to ROS 
results in the activation of Nrf2 transcriptional expression.  
 
In our study, we incubate Caco-2/15 cells with increasing concentrations of FE/ASC 
(0.05/2mM, 0.1/2mM, 0.2/2mM), which displayed different impacts on lipid peroxidation 
and on Nrf2 modulation. We observed an increase in MDA levels, a marker of lipid 
peroxidation, in a dose-dependent manner. Interestingly, at low concentrations, FE/ASC 
increased Nrf2 protein levels compared to control cells. This typical response to mild 
oxidative stress is physiologically relevant, as it could lead to Nrf2 dissociation from its 
inhibitor Keap1 and its translocation to the nucleus, thereby inducing a protective response. 
In contrast, increasing the concentration of FE/ASC (0.2/2mM) led to reduced Nrf2 protein 
levels. This may refer to severe or pathological oxidative stress observed in disease states 
and could possibly be associated with an increased Nrf2 degradation, leading to a lower 
translocation to the nucleus and an increase in oxidative stress. 
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OPZ is a chemo preventive compound that induces antioxidant protection either by 
increasing the production of ROS or by modification of Keap1 cysteine residue, ultimately 
leading to Nrf2 translocation to nucleus. In our study, optimal concentrations of OPZ (50 
µM) induced a significant increase in Nrf2 protein mass. Our findings, indicating that the 
Nrf2 knock-down blocks the protective effects of OPZ against FE/ASC, provide concrete 
evidence about the direct contribution of Nrf2 to antioxidant actions.  
 
Furthermore, the enzymatic activity of SOD, CAT and GPx was increased following OPZ 
treatment. It has been found that the level of this antioxidant was decreased in Nrf2-
depleted Caco-2/15 cells. Our findings were in agreement with a previous study showing 
that OPZ significantly reduced colitis in Nrf2-deficient mice, thereby suggesting a 
dependence of the Nrf2-ARE pathway by OPZ [159]. Further support for our data is 
evidenced by a previous report noting that sulforaphane, an OPZ activator, stimulated Nrf2 
gene–dependent antioxidant enzyme activity and protected against oxidative stress in 
gastric mucosa [172].  
 
Our results expressed the anti-inflammatory function of Nrf2. We found a significant 
decrease in NFκβ and TNFα, as well as an increase in Ικβ level upon induction of Nrf2. 
Conversely, blockage of Nrf2 induces NFκβ and TNFα up-regulation along with Iκβ  
down- regulation. Our results are consistent with a previous study by Khor et al who noted 
that the levels of pro-inflammatory mediators, such IL-6 and TNF-α, were significantly 
increased in the colonic tissues of Nrf2−/- mice as compared to their wild-type mice [158]. 
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Since inflammation has damaging effects on intestinal permeability, we suggest that Nrf2 
activation may play a protective role in intestinal permeability defects via the up-regulation 
of occludin (as it has been observed in our results) and down-regulation of pro-
inflammatory cytokines.      
 
Since the overexpression of PHB can protect against oxidative stress and inflammation 
[99], we suggest that OPZ enhances Nrf2 activation which in turn enhances the activation 
of PHB. In the current study, we demonstrated that Nrf2 activation by OPZ enhances 
mitochondrial PHB expression, while Nrf2 knockdown led to reduction of mitochondrial 
PHB. A decrease in PHB was also observed with high FE/ASC concentrations in the 
experimental system. Thus, we propose that Nrf2 is a master regulator of PHB expression. 
 
Previous data indicated that there is a regulatory mechanism between PHB and Bcl-2 [173]. 
It has been found that the activation of Nrf2 up-regulated Bcl2 expression. Bcl-2 is a well-
known molecule that has many protective functions such as antioxidant and anti-apoptotic 
ability. Taken together, our previous observations will support the Nrf2 anti-apoptotic 
function.  Therefore, we suggest that there is a functional triangle linking Nrf2, PHB and 
Bcl-2, which share anti-apoptotic and antioxidant functions. 
 
We provide for the first time evidence that Nrf2 acts as an important anti-apoptotic 
mediator and that the underlying mechanism involves activation of Bcl-2. Nrf2 induction 
by OPZ contributes to the elevation of Bcl-2 anti-apoptotic protein in Caco-2/15 cells, 
while Nrf2 knockdown or increasing FE/ASC concentrations down-regulates Bcl-2. In 
agreement with our observations, treatment with resveratrol, an OPZ activator, inhibited 
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vascular apoptotic cell death in Nrf2+/+ mice, without the same success in Nrf2-/- mice 
[174].  
 
A primary defect of the tight junctions leading to increased intestinal epithelial permeability 
has been proposed as a basic pathogenic event in chronic intestinal inflammatory diseases 
[60]. We have demonstrated the possibility that Nrf2 contributes to the regulatory function 
of intestinal TJs such as occludin. For the first time, we have shown an association between 
Nrf2 and occludin in view of the induction of Nrf2 with OPZ and the simultaneous up-
regulation of occludin. We have also observed that Caco-2/15 cells treated with Nrf2 
shRNA or with increasing concentrations of FE/ASC display reduction in occludin levels. 
Assembly of occludin at the TJ network was also observed with confocal microscopy in 
Caco-2 cells as a response of Nrf2 induction by kaempferol, a natural flavonoid [175]. 
Overall these data suggest a key role of Nrf2 in the protection of the small intestine 
integrity. 
 
Much progress has been made in uncovering the transcriptional mechanisms that govern the 
function and biogenesis of mitochondria. Mounting evidence suggests that Nrf2 acting on 
both nuclear and mitochondrial genes serves to coordinate the expression of gene products 
required for maintaining mitochondrial functions. A recent discovery of the PGC-1α family 
provides important information regarding the crosstalk between nucleus and mitochondria 
[103]. PGC-1α has the potential to integrate and utilize Nrf2 activities that have been 
implicated in the expression and function of the mitochondrial oxidative machinery.   
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Our results provide strong evidence that inducing Nrf2 activity by OPZ in Caco-2/15 cells 
contributes to mitochondrial biogenesis and function via up-regulation of PGC-1α, 
increased mitochondrial enzymatic activity and raised ATP production. Surprisingly, we 
noted a dramatic decrease in PGC-1α in Caco-2/15 cells infected with Nrf2 shRNA or 
incubated with high concentrations of FE/ASC. Our results are in agreement with a 
previous study showing a significant reduction of PGC-1α in retinal epithelial cells treated 
with oxidative stress agents [162]. Therefore, we suggest that Nrf2 acts as an independent 
transcription factor in regulating mitochondrial biogenesis. 
 
Mitochondria constitutes a primary targets for oxidant-induced intestinal epithelial injury 
and may have a central role in intestinal epithelial cell survival. As we noted previously, we 
have demonstrated that an accumulation of peroxidation products in mitochondria leads to a 
decrease in ATP production and compromises the maintenance of cellular homeostasis 
[106]. Incubation of Caco2/15 cells with Nrf2 shRNA induced a marked decrease in 
mitochondrial complex activities (Complexes I, II, III, IV) and ATP levels. In contrast, 
ATP production was significantly increased in Caco-2/15 cell following treatment with 
OPZ.  Accordingly, mitochondrial functions monitored by the levels of ATP production 
were reduced in cells treated with Nrf2 shRNA in comparison with control cells. We 
reasonably suggest that mitochondrial dysfunctions in cells treated with Nrf2 shRNA are 
due to degradation in mitochondrial respiratory chain enzymes, resulting in the decline in 
ATP production. The impairment of mitochondrial complexes activity noted in our 
experiments may partly be attributable to decreased antioxidant enzymes and increased 
oxidative stress, which ultimately led to a decrease in oxidative phosphorylation. These 
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results provide evidence to support the proposal that Nrf2 is an effective mitochondrial cell 
survival and biogenesis.  
 
Taken together, our data indicate that increased Nrf2 in intestinal epithelial cells plays a 
pivotal role in positively modulating cellular defense and maintaining cellular integrity 
against toxic insults. For the first time, our study reveals the capacity of Nrf2 to regulate 
many intestinal genes and enzymes (occludin, PHB, PGC-1α, Bcl-2) related to cell 
permeability and mitochondrial functions. It is quite possible that some of these expressed 
proteins could be secondary or indirectly attributed to Nrf2 effects. Therefore, additional 
studies are required to test this assumption. 
 
Finally, the Nrf2 multifunction protection phenomenon raises an interesting question about 
how a single protein can protect many different organs from toxic insults. A possible 
molecular mechanism explaining this phenomenon is that Nrf2 coordinately up-regulates 
classic ARE-driven genes as well as cellular type-specific genes that are required for the 
defense system. 
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7 CONCLUSION 
Considerable evidence provided in this thesis supports the importance of mitochondria as a 
critical target and event responsible for toxic oxidative stress. This is in part supported by 
the dramatic protection of cells against toxic oxidative stress following the enrichment of 
intestinal epithelial cells with Nrf2. The specific oxidative damage to mitochondrial targets 
that are directly responsible for cell injury and disease, are more difficult to define. 
However, this thesis provides compelling evidence to support the importance of different 
mitochondrial targets in oxidative stress.  
 
Evidence evidence was also provided as to the importance of mt DNA integrity in the 
maintenance of cell viability and calcium homeostasis since calcium overload was a critical 
event in mitochondrial cytochrome C release and apoptosis initiation. Furthermore, 
oxidative stress-mediated inhibition of mitochondrial complexes and limited ATP 
production appear to play a critical role in chronic intestinal inflammation.   
 
Moreover, our results have shown that Nrf2 has multiple functions beyond the classic acute 
stress responses to oxidative insults. These functions include involvement of Nrf2 in anti-
apoptotic process, mitochondrial functions, independent PGC-1α biogenesis and 
modulation of tight junction proteins such as occludin that contributes to intestinal 
permeability. 
  
The failure of antioxidant therapy strategies in clinical trials has encouraged efforts to find 
novel approaches for strengthening the endogenous antioxidant defense system, which may 
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induce mitochondrial biogenesis and anti-inflammatory responses. In this regards, Nrf2, a 
master regulator of the induction of a battery of genes able to positively influence several 
cytoprotective systems, may be a promising target to counteract mitochondrial dysfunctions 
and its consequences in IBD. Thus, exogenous Nrf2 inducers should be tested for 
therapeutic potential in IBD. 
 
Undoubtedly, future research should address several exciting issues: 
1. Do Nrf2-activating drugs (such as OPZ) display comparable effects like nutritional 
agents (such as resveratrol)? 
2. Are Nrf2 target genes or their expression level quite different depending on the 
Nrf2-activating signal? 
3. Can Nrf2 activity be pharmacologically or nutritionally manipulated in a safe 
manner to help ameliorate IBD or other intestinal inflammatory diseases? 
 
We hope that further work in the next years will uncover Nrf2 effectiveness in terms of the 
reduction of mitochondrial oxidative damage in IBD and the beneficial outcome of patients 
with mitochondrial diseases. If our proposal is proved true in large clinical studies, this 
strategy might slow the progression of IBD. 
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